Processing 00000000.tx.1: Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid- Peptides* Philippe Marambaud1, Haitian Zhao, and Peter Davies From the Litwin-Zucker Research Center for the Study of Alzheimer's Disease and Memory Disorders, North Shore-Long Island Jewish Institute for Medical Research, Manhasset, New York 11030 Received for publication, July 27, 2005 , and in revised form, September 12, 2005.  

Phrase: "Resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "Promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "Clearance of Alzheimer's Disease Amyloid- Peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "* Philippe Marambaud1,"

Phrase: "Haitian Zhao,"

Phrase: "and"

Phrase: "Peter Davies From the Litwin-Zucker Research Center"

Phrase: "for the Study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "of Alzheimer's Disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "Memory Disorders,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025261:Memory Disorders [Mental or Behavioral Dysfunction]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "North Shore-Long Island Jewish Institute for Medical Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0035172:Research Institute [Organization]
   742   C0021622:institute [Organization]
   742   C1272753:Institute [Idea or Concept]

Phrase: "Manhasset,"

Phrase: "New York 11030"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "July 27,"

Phrase: "2005 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "September 12,"

Phrase: "2005."
Processing 00000000.tx.2: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Several epidemiological studies indicate that moderate consumption of wine is associated with a lower incidence of Alzheimer's disease. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Several epidemiological studies"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0002783:Epidemiological Studies [Research Activity]
   827   C0014507:Epidemiological [Biomedical Occupation or Discipline]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   755 E C0014508:epidemiology [Functional Concept]
   755 E C0699910:epidemiology [Health Care Activity]

Phrase: "indicate"

Phrase: "that moderate consumption of wine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0009830:Consumption [Activity]
   760   C1947907:Consumption [Physiologic Function]

Phrase: "is"

Phrase: "associated with a lower incidence of Alzheimer's disease."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   767   C0243083:associated disease [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0021149:Incidence [Quantitative Concept]
   744   C0220856:incidence [Functional Concept]
   744   C0441994:Lower [Spatial Concept]
   744   C1548802:Lower [Body Location or Region]
   744   C2003888:Lower [Activity]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.3: Wine is enriched in antioxidant compounds with potential neuroprotective activities. 

Phrase: "Wine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043188:Wine [Food]

Phrase: "is"

Phrase: "enriched in antioxidant compounds"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003402:Antioxidant [Pharmacologic Substance]
   770   C0359583:enriched [Food]
   737   C0205198:Compound [Qualitative Concept]
   737   C1706082:Compound [Chemical]

Phrase: "with potential neuroprotective activities."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.4: However, the exact molecular mechanisms involved in the beneficial effects of wine intake on the neurodegenerative process in Alzheimer's disease brain remain to be clearly defined. 

Phrase: "However,"

Phrase: "the exact molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in the beneficial effects of wine intake"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0559432:Wine intake [Finding]
   744   C0043188:Wine [Food]
   744   C1280500:effects [Qualitative Concept]
   744   C1314939:Involved [Functional Concept]
   744   C1512806:Intake [Functional Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on the neurodegenerative process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "in Alzheimer's disease brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "clearly"

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.5: Here we show that resveratrol (trans-3,4',5-trihydroxystilbene), a naturally occurring polyphenol mainly found in grapes and red wine, markedly lowers the levels of secreted and intracellular amyloid- (A) peptides produced from different cell lines. 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "(trans-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2826298:TRANS [Idea or Concept]

Phrase: "4',"

Phrase: "5-trihydroxystilbene"

Phrase: ")"

Phrase: ","

Phrase: "a naturally"

Phrase: "occurring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1709305:Occur [Activity]
   966   C2745955:OCCUR [Temporal Concept]

Phrase: "polyphenol mainly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0071649:Polyphenol [Organic Chemical,Pharmacologic Substance]
   861   C2348280:Polyphenol [Organic Chemical]

Phrase: "found in grapes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018208:Grapes [Food]
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]
   756 E C1365537:grape [Food]

Phrase: "and"

Phrase: "red wine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0349371:Red wine [Food]
   861   C0043188:Wine [Food]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "lowers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "the levels of secreted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "intracellular amyloid- (A) peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "produced from different cell lines."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0007600:Cell lines [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1705242:Different [Qualitative Concept]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.6: Resveratrol does not inhibit A production, because it has no effect on the A-producing enzymes - and -secretases, but promotes instead intracellular degradation of A via a mechanism that involves the proteasome. 

Phrase: "Resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "A production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "because"

Phrase: "it"

Phrase: "has"

Phrase: "no effect on the A-"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1301751:No effect [Qualitative Concept]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1280500:Effect [Qualitative Concept]
   760   C1298908:no [Idea or Concept]
   760   C1549444:No [Idea or Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "producing enzymes -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "and -"

Phrase: "secretases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "instead intracellular degradation of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "via a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "involves"

Phrase: "the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.7: Indeed, the resveratrol-induced decrease of A could be prevented by several selective proteasome inhibitors and by siRNA-directed silencing of the proteasome subunit 5. 

Phrase: "Indeed,"

Phrase: "the resveratrol-induced decrease of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "prevented by several selective proteasome inhibitors"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   790   C2266856:Proteasome Inhibitors [Molecular Function]
   756 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   753   C1325620:proteasome [Cell Component]
   753   C1752727:Proteasome [Molecular Function]
   719   C0309872:PREVENT [Pharmacologic Substance]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and by siRNA-directed silencing of the proteasome subunit 5."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1099354:siRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   739   C1325620:proteasome [Cell Component]
   739   C1515981:And [Idea or Concept]
   739   C1711351:Subunit [Quantitative Concept]
   739   C1752727:Proteasome [Molecular Function]
   706   C0858952:silence [Mental or Behavioral Dysfunction]
Processing 00000000.tx.8: These findings demonstrate a proteasome-dependent anti-amyloidogenic activity of resveratrol and suggest that this natural compound has a therapeutic potential in Alzheimer's disease.  

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "a proteasome-dependent anti-amyloidogenic activity of resveratrol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1622946:proteasome activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this natural compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205198:Compound [Qualitative Concept]
   861   C1706082:Compound [Chemical]

Phrase: "has"

Phrase: "a therapeutic potential in Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.9: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Alzheimer's disease (AD)2 is a progressive neurodegenerative disorder leading to the most common form of dementia. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)2"

Phrase: "is"

Phrase: "a progressive neurodegenerative disorder"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1864985:Progressive disorder [Finding]
   901   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   827   C0012634:Disorder [Disease or Syndrome]

Phrase: "leading to the most common form of dementia."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0205214:Common [Quantitative Concept]
   744   C0332152:Leading [Temporal Concept]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]
   744   C1522138:Common [Functional Concept]
   744   C1522492:Form [Functional Concept]
   744   C1522538:Leading [Functional Concept]
   744   C3245511:common [Intellectual Product]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.10: Compelling evidence supports the central role of A in the pathogenesis of the disease (1). 

Phrase: "Compelling evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the central role of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.11: A is a core component of the senile plaque, a classical lesion found in the neocortex and hippocampus of AD brains, and excessive production of the highly insoluble 42-amino acid-long A42 peptide is almost invariably observed in the presence of mutations in the three genes linked to early onset autosomal dominant familial forms of AD (2). 

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a core component of the senile plaque,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "a classical lesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0221198:Lesion [Finding]
   861   C1546698:Lesion [Intellectual Product]

Phrase: "found in the neocortex"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0150312:Found [Quantitative Concept]
   770   C0175173:Neocortex [Body Part, Organ, or Organ Component]
   737 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "hippocampus of AD brains,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C0019564:BRAIN, HIPPOCAMPUS [Body Part, Organ, or Organ Component]
           Hippocampus
   770   C0949582:Hippocampus [Fish]
   770   C1029104:Hippocampus [Fish]
   770   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "excessive production of the highly insoluble 42-amino acid-long A42 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "almost invariably"

Phrase: "observed in the presence of mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0026882:Mutations [Genetic Function]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1441672:Observed [Functional Concept]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the three genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "linked to early onset autosomal dominant familial forms of AD (2"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   772   C0265385:AD - Autosomal dominant [Disease or Syndrome]
   772   C0443147:AD - Autosomal dominant [Intellectual Product]
           Autosomal dominant
   756   C1833334:Early-onset [Finding]
   739   C1832428:Familial form [Finding]
   738   C0015576:familial [Family Group]
   738   C0241888:Familial [Functional Concept]
   738   C0332162:Onset [Qualitative Concept]
   738   C0348078:forms [Qualitative Concept]
   738   C0376315:Forms [Manufactured Object]
   738   C0596142:autosomal [Cell Component]
   738   C1279919:Early [Temporal Concept]
   738   C1527180:Dominant [Functional Concept]
   704   C1517892:Link [Intellectual Product]
   704 E C1522492:Form [Functional Concept]
   704   C1704666:Link [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.12: In the amyloidogenic pathway, the amyloid- precursor protein (APP) is cleaved by the aspartic protease -secretase/BACE1 to yield the membrane-anchored C-terminal fragments C99 and C89. 

Phrase: "In the amyloidogenic pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "the amyloid- precursor protein (APP)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "cleaved by the aspartic protease -secretase/BACE1 to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C2717969:Aspartic Protease [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205242:Cleaved [Spatial Concept]
   744   C0333853:Cleaved [Cell]
   744   C1412727:BACE1 [Gene or Genome]
   744   C1947941:Protease [Enzyme]

Phrase: "yield"

Phrase: "the membrane-anchored C-terminal fragments C99"

Phrase: "and"

Phrase: "C89."
Processing 00000000.tx.13: C99 is then endoproteolyzed by the -secretase proteolytic complex to produce various A peptides. 

Phrase: "C99"

Phrase: "is"

Phrase: "then endoproteolyzed by the -secretase proteolytic complex to"

Phrase: "produce"

Phrase: "various A peptides."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.14: The major cleavage takes place after Val-40 producing A40. 

Phrase: "The major cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place after Val-40 producing A40."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0442504:Place [Spatial Concept]
   753   C1704765:Place [Functional Concept]
   753   C1882509:Place [Activity]
   753   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.15: In an alternative nonamyloidogenic pathway, APP is endoproteolyzed within the A region by -secretase to generate the C-terminal fragment C83 and the soluble N-terminal fragment secreted APP. 

Phrase: "In an alternative nonamyloidogenic pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "endoproteolyzed within the A region"

Phrase: "by -secretase to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "generate"

Phrase: "the C-terminal fragment C83"

Phrase: "and"

Phrase: "the soluble N-terminal fragment secreted APP."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   835   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   835   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   822   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0011560:Amyloid [Pathologic Function]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1327616:Secreted [Cell Function]
   793   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.16: Finally, a -secretase-mediated -cleavage of APP allows the intracellular release of the transcriptionally active APP intracellular domain (AID (3) or AICD) (46). 

Phrase: "Finally,"

Phrase: "a -secretase-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mediated -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0597304:Protein Cleavage [Molecular Function]
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the intracellular release of the transcriptionally active APP intracellular domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   736   C0030685:Release [Health Care Activity]
   736   C0391871:Release [Functional Concept]
   736   C0439180:% release [Quantitative Concept]
   736   C0680255:release [Health Care Activity]
   736   C1283071:Release [Functional Concept]
   736   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(AID (3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018896:Aid [Social Behavior]
   861   C0449435:Aid [Manufactured Object]
   861   C3540469:AID [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "AICD) (46"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0972395:aicd [Medical Device]
   861   C2611803:AICD [Cell Function]
   861   C3156099:AICD [Cell Function]
   861   C3537205:AICD [Cell Function]

Phrase: ")."
Processing 00000000.tx.17: Epidemiological studies have shown that moderate wine intake reduces the risk of developing AD (710). 

Phrase: "Epidemiological studies"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0002783:Epidemiological Studies [Research Activity]
   861   C0014507:Epidemiological [Biomedical Occupation or Discipline]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   789 E C0014508:epidemiology [Functional Concept]
   789 E C0699910:epidemiology [Health Care Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that moderate wine intake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0559432:Wine intake [Finding]
   827   C1512806:Intake [Functional Concept]

Phrase: "reduces"

Phrase: "the risk of developing AD (710"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035647:Risk [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.18: Resveratrol, a polyphenol that occurs in abundance in grapes and red wine, is suspected to afford antioxidant and neuroprotective properties and therefore to contribute to the beneficial effect of wine consumption on the neurodegenerative process (1113). 

Phrase: "Resveratrol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "a polyphenol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0071649:Polyphenol [Organic Chemical,Pharmacologic Substance]
  1000   C2348280:Polyphenol [Organic Chemical]

Phrase: "that"

Phrase: "occurs in abundance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1709305:Occur [Activity]
   790   C2346714:Abundance [Qualitative Concept]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "in grapes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018208:Grapes [Food]
   966 E C1365537:grape [Food]

Phrase: "and"

Phrase: "red wine,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0349371:Red wine [Food]
   861   C0043188:Wine [Food]
   861   C0332575:Red [Finding]
   861   C1260956:Red [Qualitative Concept]

Phrase: "is"

Phrase: "suspected to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332147:Suspected [Qualitative Concept]
   833   C0750491:Suspected [Idea or Concept]
   799 E C1571873:Suspect [Idea or Concept]

Phrase: "afford"

Phrase: "antioxidant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidant [Pharmacologic Substance]

Phrase: "and"

Phrase: "neuroprotective properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "and"

Phrase: "therefore to"

Phrase: "contribute to the beneficial effect of wine consumption"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0009830:Consumption [Activity]
   744   C0043188:Wine [Food]
   744   C1280500:Effect [Qualitative Concept]
   744   C1880177:Contribute [Activity]
   744   C1947907:Consumption [Physiologic Function]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on the neurodegenerative process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "(1113"

Phrase: ")."
Processing 00000000.tx.19: Here we report that resveratrol has a potent anti-amyloidogenic activity by reducing the levels of A produced from different cell lines expressing wild type or Swedish mutant APP695. 

Phrase: "Here"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "has"

Phrase: "a potent anti-amyloidogenic activity by reducing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "the levels of A"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "produced from different cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0007600:Cell lines [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1705242:Different [Qualitative Concept]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "Swedish mutant APP695."
Processing 00000000.tx.20: We show that resveratrol acts by promoting the intracellular degradation of A by a mechanism that implicates the proteasome.  

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "acts by promoting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033414:Promoting [Activity]
   790   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "the intracellular degradation of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "by a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "implicates"

Phrase: "the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.21: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Materials and AntibodiesQuercetin, catechin, resveratrol, piceatannol, phosphoramidon, thiorphan, insulin, N-succinyl-LLVY-7-amido-4-methylcoumarin (Suc-LLVY-AMC), and Suc-AAF-AMC were obtained from Sigma. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "AntibodiesQuercetin,"

Phrase: "catechin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007404:Catechin [Organic Chemical,Pharmacologic Substance]

Phrase: "resveratrol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "piceatannol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1176007:piceatannol [Organic Chemical,Pharmacologic Substance]

Phrase: "phosphoramidon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "thiorphan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039945:Thiorphan [Organic Chemical,Pharmacologic Substance]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "N-succinyl-LLVY-7-amido-4-methylcoumarin (Suc-LLVY-AMC),"

Phrase: "and"

Phrase: "Suc-AAF-AMC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0763892:AAF-AMC [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "obtained from Sigma."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1301820:Obtained [Functional Concept]
   790   C1719918:Sigma [Intellectual Product]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.22: Trimethoxy-resveratrol and TMS (trans-2,3',4,5'-tetramethoxystilbene) were from Cayman Chemical. 

Phrase: "Trimethoxy-resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "TMS (trans-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1822679:TMS-2 [Gene or Genome]
   827   C2826298:TRANS [Idea or Concept]

Phrase: "3',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5'-tetramethoxystilbene"

Phrase: ")"

Phrase: "were from Cayman"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0079078:Caiman [Reptile]

Phrase: "Chemical."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220806:Chemical [Chemical]
  1000   C3272558:Chemical [Intellectual Product]
Processing 00000000.tx.23: L-685,458, lactacystin, Z-GPFL-CHO, YU101, and N-acetyl-LL-norleucinal-CHO (ALLN) were from Calbiochem. 

Phrase: "L-685,458,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0915177:L-685,458 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0439394:l's [Quantitative Concept]
   827   C1706495:L- [Intellectual Product]
   827   C3642217:/L [Quantitative Concept]

Phrase: "lactacystin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "Z-GPFL-CHO,"

Phrase: "YU101,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1565728:YU101 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "N-acetyl-LL-norleucinal-CHO (ALLN)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1553036:[n] [Quantitative Concept]

Phrase: "were from Calbiochem."
Processing 00000000.tx.24: Purified human 20 S proteasome was from Biomol. 

Phrase: "Purified human 20 S proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1325620:proteasome [Cell Component]
   804   C1752727:Proteasome [Molecular Function]

Phrase: "was from Biomol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.25: Anti-A-(117) (6E10) and anti-A-(1724) (4G8, pure and biotinylated) antibodies were from Signet. 

Phrase: "Anti-A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "-"

Phrase: "(117"

Phrase: ")"

Phrase: "(6E10"

Phrase: ")"

Phrase: "and"

Phrase: "anti-A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "-"

Phrase: "(1724"

Phrase: ")"

Phrase: "(4G8,"

Phrase: "pure"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2247561:PurE [Molecular Function]
   928 E C1882508:Purity [Quantitative Concept]

Phrase: "and"

Phrase: "biotinylated"

Phrase: ")"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were from Signet."
Processing 00000000.tx.26: Anti-APP-(6681) (22C11) antibody was from Chemicon, and anti-APP C-terminal domain (R1) antibody was provided by Dr. 

Phrase: "Anti-APP-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(6681"

Phrase: ")"

Phrase: "(22C11"

Phrase: ")"

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was from Chemicon,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]

Phrase: "and"

Phrase: "anti-APP C-terminal domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   845   C0162808:Protein Domain [Spatial Concept]
   845   C1514562:Protein Domain [Amino Acid Sequence]
   795   C1880389:Domain [Functional Concept]
   795   C1883221:Domain [Conceptual Entity]
   795   C3541951:Domain [Intellectual Product]

Phrase: "(R1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1335648:R1 [Gene or Genome]
  1000   C1824685:R1 [Gene or Genome]
  1000   C2697937:R1 [Quantitative Concept]

Phrase: ")"

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.27: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.28: D. 

Phrase: "D."
Processing 00000000.tx.29: Mehta, Institute for Basic Research in Developmental Disabilities, Staten Island, NY. 

Phrase: "Mehta,"

Phrase: "Institute for Basic Research"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0035172:Research Institute [Organization]
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "in Developmental Disabilities,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
  1000   C0008073:Developmental Disabilities [Mental or Behavioral Dysfunction]
  1000   C1552527:Developmental Disabilities [Health Care Related Organization,Manufactured Object]
   861   C0231170:Disabilities [Finding]
   861   C0458003:Developmental [Qualitative Concept]
   861   C0678723:Developmental [Organism Function]
   789 E C0243107:development [Physiologic Function]
   789 E C1527148:Development [Functional Concept]
   777 E C0018576:Disabled [Patient or Disabled Group]
   777 E C1880351:Disabled [Qualitative Concept]

Phrase: "Staten Island,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022130:Island [Geographic Area]

Phrase: "NY."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]
Processing 00000000.tx.30: Polyclonal antibodies specific for A40 (FCA3340) or A42 (FCA3542) (14) were obtained from Dr. 

Phrase: "Polyclonal antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "specific for A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "(FCA3340"

Phrase: ")"

Phrase: "or"

Phrase: "A42"

Phrase: "(FCA3542"

Phrase: ")"

Phrase: "(14"

Phrase: ")"

Phrase: "were"

Phrase: "obtained from Dr."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1301820:Obtained [Functional Concept]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.31: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.32: Checler, IPMC-Centre National de la Recherche Scientifique, Valbonne, France. 

Phrase: "Checler,"

Phrase: "IPMC-Centre National de la Recherche Scientifique,"

Phrase: "Valbonne,"

Phrase: "France."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]
Processing 00000000.tx.33: Anti-N-cadherin (C32) and anti--catenin antibodies were from BD Transduction Laboratories. 

Phrase: "Anti-N-cadherin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0432633:Anti N [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1413274:cadherin [Gene or Genome]

Phrase: "(C32"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1421906:C32 [Gene or Genome]
  1000   C2700320:C32 [Fish]

Phrase: ")"

Phrase: "and"

Phrase: "anti"

Phrase: "--"

Phrase: "catenin antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were from BD Transduction Laboratories."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C1160185:transduction [Organism Function]
   760   C1619828:Laboratories [Intellectual Product]
   726 E C3244292:laboratory [Functional Concept]
Processing 00000000.tx.34: Anti-20 S proteasome subunit 5 antibody was from ABR Affinity BioReagents, and the polyclonal antibody directed against the subunits 5, 7, 1, 5, 5i, and 7 of the 20 S proteasome was from Biomol. 

Phrase: "Anti-20 S proteasome subunit 5 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   893   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was from ABR Affinity BioReagents,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1412101:ABR [Gene or Genome]
   760   C1421478:WAS [Gene or Genome]
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "the polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against the subunits 5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0439851:Direct [Qualitative Concept]
   726   C1711351:Subunit [Quantitative Concept]
   726   C1947931:Direct [Qualitative Concept]

Phrase: "7,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "5i,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552169:5i [Medical Device]

Phrase: "and"

Phrase: "7 of the 20 S proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1325620:proteasome [Cell Component]
   753   C1752727:Proteasome [Molecular Function]

Phrase: "was from Biomol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.35: Anti--tubulin antibody was from Santa Cruz Biotechnology. 

Phrase: "Anti--tubulin antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was from Santa Cruz Biotechnology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.36: Cell Lines, Transfections, and Drug TreatmentsHEK293 cells stably transfected with human APP695 were provided by Dr. 

Phrase: "Cell Lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "Transfections,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "Drug TreatmentsHEK293 cells stably"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with human APP695"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086418:Human [Human]

Phrase: "were"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.37: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.38: D'Adamio, Albert Einstein College of Medicine, Bronx, NY. 

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "Albert Einstein College of Medicine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0013227:Medicine, NOS [Pharmacologic Substance]
   804   C0025118:Medicine [Biomedical Occupation or Discipline]
   804   C0557806:College [Manufactured Object]

Phrase: "Bronx,"

Phrase: "NY."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]
Processing 00000000.tx.39: N2a cells were stably transfected with wild type or Swedish mutant human APP695 cDNAs (obtained from Dr. N. K. Robakis, Mount Sinai School of Medicine, New York, NY). 

Phrase: "N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stably"

Phrase: "transfected with wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "Swedish mutant human APP695 cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "obtained from Dr. N. K. Robakis,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0031831:DR [Professional or Occupational Group]
   753   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1301820:Obtained [Functional Concept]
   753   C1707664:DR [Biomedical or Dental Material]
   753   C1708601:K' [Quantitative Concept]
   753   C2348314:Dr. [Conceptual Entity]
   753   C3540849:DR [Idea or Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "Mount Sinai School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.40: APP695-HEK293 transfectants were grown in Dulbecco's modified Eagle's medium plus 10% fetal bovine serum, penicillin and streptomycin, and 5 g/ml puromycin. 

Phrase: "APP695-HEK293 transfectants"

Phrase: "were"

Phrase: "grown in Dulbecco's modified Eagle's medium plus 10% fetal bovine serum,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   738   C0007452:Bovine [Mammal]
   738   C0009458:Medium [Intellectual Product]
   738   C0015965:Fetal [Embryonic Structure]
   738   C0229671:Serum [Body Substance]
   738   C0325564:Eagle [Bird]
   738   C0332287:Plus [Qualitative Concept]
   738   C0392747:Modified [Functional Concept]
   738   C0439536:Medium [Quantitative Concept]
   738   C0521457:Fetal [Functional Concept]
   738   C1140701:bovine [Mammal]
   738   C1546774:Serum [Intellectual Product]
   738   C1550100:Serum [Body Substance]
   738   C1551720:Eagle [Population Group]
   738   C1705217:Medium [Substance]
   738   C3244283:medium [Intellectual Product]

Phrase: "penicillin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030842:Penicillin [Antibiotic,Organic Chemical]
  1000   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "5 g/ml puromycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034145:Puromycin [Antibiotic,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.41: APP695-N2a cells were maintained in 1:1 Dulbecco's modified Eagle's medium/Opti-MEM supplemented with 5% fetal bovine serum, penicillin and streptomycin, and 0.2 mg/ml G418. 

Phrase: "APP695-N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained in 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: ":"

Phrase: "1 Dulbecco's modified Eagle's medium/Opti-MEM"

Phrase: "supplemented with 5% fetal bovine serum,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "penicillin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030842:Penicillin [Antibiotic,Organic Chemical]
  1000   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "0.2 mg/ml G418."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0052009:G418 [Antibiotic,Organic Chemical]
Processing 00000000.tx.42: For drug treatments, cells were treated at confluence for the indicated concentrations and incubation times. 

Phrase: "For drug treatments,"
Meta Candidates (Total=11; Excluded=8; Pruned=0; Remaining=3)
   861   C0013227:Drug [Pharmacologic Substance]
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   861   C1254351:Drug [Pharmacologic Substance]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated at confluence"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332293:treated [Therapeutic or Preventive Procedure]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
   718   C0205200:Confluent [Qualitative Concept]

Phrase: "for the indicated concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "incubation times."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.43: Medium was then changed, and treatments were continued for another 2 h to allow A secretion. 

Phrase: "Medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "treatments"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0087111:Treatments [Therapeutic or Preventive Procedure]
   966 E C0039798:treatment [Functional Concept]
   966 E C1522326:Treatment [Functional Concept]
   966 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   966 E C1705169:Treatment [Conceptual Entity]
   966 E C3538994:TREATMENT [Research Activity]

Phrase: "were"

Phrase: "continued for another 2 h to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0011744:h 2 [Element, Ion, or Isotope]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0549178:Continued [Idea or Concept]
   753   C0564385:/h [Quantitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "A secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.44: For siRNA-directed silencing, 200 pmol of purified siRNA directed against the proteasome subunit 5 (SMARTpool, Dharmacon) were transfected with 10 l of Lipofectamine 2000 (Invitrogen) in APP695-HEK293 cells plated in 35-mm dishes. 

Phrase: "For siRNA-directed silencing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "200 pmol of purified siRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439192:pmol [Quantitative Concept]

Phrase: "directed against the proteasome subunit 5"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1325620:proteasome [Cell Component]
   753   C1711351:Subunit [Quantitative Concept]
   753   C1752727:Proteasome [Molecular Function]
   719   C0439851:Direct [Qualitative Concept]
   719   C1947931:Direct [Qualitative Concept]

Phrase: "(SMARTpool,"

Phrase: "Dharmacon"

Phrase: ")"

Phrase: "were"

Phrase: "transfected with 10 l of Lipofectamine 2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1312445:lipofectamine 2000 [Organic Chemical]
   748   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "in APP695-HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2936239:HEK293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "plated in 35-mm dishes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C0005971:Plate [Medical Device]
   726   C0020498:DISH [Disease or Syndrome]
   726   C1139930:plate [Medical Device]
   726   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.45: At 48 h post-transfection, cells were incubated in the absence or presence of 40 M resveratrol for another 24 h. 

Phrase: "At 48 h post-transfection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "presence of 40 M resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "for another 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.46: Cells and conditioned medium were harvested and analyzed by Western blotting (WB) and by proteasome activity assays as described below. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "analyzed by Western blotting (WB)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "and by proteasome activity assays"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C1622946:proteasome activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1325620:proteasome [Cell Component]
   760   C1515981:And [Idea or Concept]
   760   C1561536:*Activity [Idea or Concept]
   760   C1752727:Proteasome [Molecular Function]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "described below."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]
Processing 00000000.tx.47: Western BlottingCells were washed with phosphate-buffered saline and solubilized in ice-cold HEPES buffer (25 mM HEPES, pH 7.4, 150 mM NaCl, 1x Complete protease inhibitor mixture, Roche Applied Science) containing 1% SDS. 

Phrase: "Western BlottingCells"

Phrase: "were"

Phrase: "washed with phosphate-buffered saline"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "solubilized in ice-cold HEPES buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0456963:Ice cold [Qualitative Concept]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0009264:Cold [Natural Phenomenon or Process]
   753   C0009443:Cold [Disease or Syndrome]
   753   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0020746:Ice [Inorganic Chemical]
   753   C0234192:Cold [Physiologic Function]

Phrase: "(25 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1x Complete protease inhibitor mixture,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439962:Mixture [Substance]

Phrase: "Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% SDS."
Processing 00000000.tx.48: Ten micrograms of extracts were analyzed by SDS-PAGE. 

Phrase: "Ten micrograms of extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439211:microgram [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by SDS-PAGE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]
Processing 00000000.tx.49: For total sA WB, conditioned medium was subjected to 0.2-m filtration. 

Phrase: "For total sA WB,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   844 E C0949466:Western Blot [Laboratory Procedure]
   812   C1705493:Western [Spatial Concept]

Phrase: "conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "subjected to 0.2-m filtration."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0016107:filtration [Laboratory Procedure]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]
Processing 00000000.tx.50: Twenty microliters of medium were then electrophoresed on 16.5% Tris-Tricine gels and transferred onto 0.2-m nitrocellulose membranes. 

Phrase: "Twenty microliters of medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0009458:Medium [Intellectual Product]
   812   C0439536:Medium [Quantitative Concept]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "electrophoresed on 16.5% Tris-Tricine gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   748   C0077068:tricine [Organic Chemical]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0814229:TRI [Intellectual Product]
   714   C0013855:electrophorese [Laboratory Procedure]
   714 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "transferred onto 0.2-m nitrocellulose membranes."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   748   C0025255:Membranes [Tissue]
   748   C0348011:transferred [Functional Concept]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   714 E C0040671:Transfer [Mental Process]
   714 E C0596901:Membrane [Cell Component]
   714 E C1705822:Transfer [Activity]
   714 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.51: Membranes were microwaved for 5 min in phosphate-buffered saline, blocked in 5% fat-free milk in TBS, and incubated with 6E10 (1:1000 in Pierce SuperBlock) overnight at 4 C. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "microwaved for 5 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   737   C0026051:Microwave [Natural Phenomenon or Process]

Phrase: "in phosphate-buffered saline,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "blocked in 5% fat-free milk"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   783   C0991850:MILK FAT [Lipid,Pharmacologic Substance]
   753   C0026131:Milk [Body Substance]
   753   C0028778:Blocked [Pathologic Function]
   753   C0332206:Blocked [Functional Concept]
   753   C0332296:free [Functional Concept]
   753   C0349374:Milk [Food]
   753   C0424612:FAT [Organism Attribute]
   753   C0444318:Milk [Substance]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C2825079:Milk [Food]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "in TBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: "and"

Phrase: "incubated with 6E10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000 in Pierce SuperBlock"

Phrase: ")"

Phrase: "overnight at 4 C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.52: A standard ECL detection procedure was then used. 

Phrase: "A standard ECL detection procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   804   C1948041:Procedure [Therapeutic or Preventive Procedure]
   804   C2700391:Procedure [Activity]
   804   C3274430:PROCEDURE [Health Care Activity]
   804   C3538935:Procedure [Idea or Concept]
   804   C3539779:Procedure [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.53: A Immunoprecipitations (IPs)Cells were solubilized in ice-cold RIPA buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 0.1% SDS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 1x Complete). 

Phrase: "A Immunoprecipitations (IPs)Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "solubilized in ice-cold RIPA buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0456963:Ice cold [Qualitative Concept]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0009264:Cold [Natural Phenomenon or Process]
   753   C0009443:Cold [Disease or Syndrome]
   753   C0020746:Ice [Inorganic Chemical]
   753   C0034584:RIPA [Laboratory Procedure]
   753   C0234192:Cold [Physiologic Function]

Phrase: "(50 mM Tris-HCl,"

Phrase: "pH 8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.1% SDS,"

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "0.5% sodium deoxycholate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037500:SODIUM DESOXYCHOLATE [Pharmacologic Substance,Steroid]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "1x"

Phrase: "Complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.54: Five hundred micrograms of cell extracts (for total intracellular A IP) or 1 ml of the corresponding conditioned medium diluted in 4x RIPA buffer (for sA40 and sA42 IPs) were precleared with protein A- or protein G-Sepharose (Amersham Biosciences) for 2 h at 4C. 

Phrase: "Five hundred micrograms of cell extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439211:microgram [Quantitative Concept]

Phrase: "("

Phrase: "for total intracellular A IP)"

Phrase: "or"

Phrase: "1 ml of the corresponding conditioned medium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439526:/mL [Quantitative Concept]

Phrase: "diluted in 4x RIPA buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0034584:RIPA [Laboratory Procedure]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "("

Phrase: "for sA40"

Phrase: "and"

Phrase: "sA42 IPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: ")"

Phrase: "were"

Phrase: "precleared with protein A"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "-"

Phrase: "or"

Phrase: "protein G-Sepharose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036681:Sepharose [Carbohydrate]
   734   C0060916:protein g [Amino Acid, Peptide, or Protein]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.55: Supernatants were then incubated overnight at 4 C with 3 l of antibodies 4G8 (total intracellular A IP), FCA3340 (sA40 IP), or FCA3542 (sA42 IP). 

Phrase: "Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 4 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]

Phrase: "with 3 l"

Phrase: "of antibodies 4G8"

Phrase: "(total intracellular A IP"

Phrase: ")"

Phrase: ","

Phrase: "FCA3340"

Phrase: "(sA40 IP"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "FCA3542"

Phrase: "(sA42 IP"

Phrase: ")."
Processing 00000000.tx.56: Supernatants were then treated for 2 h at 4 C with protein A-Sepharose (polyclonal antibodies) or with protein G-Sepharose (monoclonal antibodies). 

Phrase: "Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated for 2 h"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "at 4 C"

Phrase: "with protein A-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332287:With [Qualitative Concept]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1705690:With [Intellectual Product]

Phrase: "Sepharose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036681:Sepharose [Carbohydrate]

Phrase: "(polyclonal antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "or with protein G-Sepharose"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797 E C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Sepharose [Carbohydrate]
   760   C0439267:g% [Quantitative Concept]

Phrase: "(monoclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0746619:monoclonal [Finding]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.57: IPs were washed with ice-cold RIPA buffer and analyzed by WB using the 6E10 antibody as described above. 

Phrase: "IPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "were"

Phrase: "washed with ice-cold RIPA buffer"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0456963:Ice cold [Qualitative Concept]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0009264:Cold [Natural Phenomenon or Process]
   753   C0009443:Cold [Disease or Syndrome]
   753   C0020746:Ice [Inorganic Chemical]
   753   C0034584:RIPA [Laboratory Procedure]
   753   C0234192:Cold [Physiologic Function]
   753   C1548982:Washed [Idea or Concept]
   719 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 6E10 antibody as described above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.58: A Enzyme-linked Immunosorbent Assay (ELISA) 6E10 (capture antibody) was coated at 2 g/ml in coating buffer (2.27 g/liter K2HPO4, 3.48 g/liter KH2PO4, pH 7.2, 8 g/liter NaCl, 0.372 g/liter EDTA, 0.1 g/liter NaN3) into 96-well immunoassay plates for 24 h at 4 C. 

Phrase: "A Enzyme-linked Immunosorbent Assay (ELISA) 6E10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]

Phrase: "(capture antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "coated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522408:Coated [Qualitative Concept]
   966 E C0453946:Coat [Manufactured Object]
   966 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "at 2 g/ml in coating buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C1300565:g/mL [Quantitative Concept]
   774 E C1637390:mL/g [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]

Phrase: "(2.27 g/liter K2HPO4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0138037:K2HPO4 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "3.48 g/liter KH2PO4,"

Phrase: "pH 7.2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "8 g/liter NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.372 g/liter EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.1 g/liter NaN3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0074721:NaN3 [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: "into 96-well immunoassay"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020980:Immunoassay [Laboratory Procedure]
   827   C0021060:immunoassay [Laboratory Procedure]

Phrase: "plates for 24 h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0005971:Plate [Medical Device]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1139930:plate [Medical Device]
   770   C3537155:Plate [Manufactured Object]

Phrase: "at 4 C."
Processing 00000000.tx.59: The plates were washed with 0.05% Tween 20 in TBS (TTBS) and blocked with Pierce TBS starting block buffer for 1 h at room temperature. 

Phrase: "The plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "washed with 0.05% Tween 20"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   762 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   753   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   753   C1548982:Washed [Idea or Concept]
   719 E C0441648:Wash [Activity]

Phrase: "in TBS (TTBS"

Phrase: ")"

Phrase: "and"

Phrase: "blocked with Pierce TBS starting block buffer"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0028778:Blocked [Pathologic Function]
   748   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   748   C0332206:Blocked [Functional Concept]
   748   C1532188:Tbsp [Quantitative Concept]
   748   C2983591:BLOCKED [Research Activity]
   714   C0439659:Start [Temporal Concept]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.60: The samples (conditioned medium or A140 standards) and biotinylated 4G8 (reporter antibody, at 0.5 g/ml in 20% Pierce SuperBlock) were then added to the plates and incubated at room temperature for 2 h. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "(conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "or"

Phrase: "A140 standards"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0038137:standards [Intellectual Product]
   861   C0175675:Standards [Qualitative Concept]
   827 E C1442989:Standard [Qualitative Concept]
   827 E C2828392:Standard [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "biotinylated 4G8"

Phrase: "(reporter antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "at 0.5 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "in 20% Pierce SuperBlock"

Phrase: ")"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added to the plates"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1139930:plates [Medical Device]
   770   C1524062:Added [Functional Concept]
   737 E C0005971:Plate [Medical Device]
   737 E C1883712:Add [Functional Concept]
   737 E C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "incubated at room temperature"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1547703:Room [Spatial Concept]

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.61: Following washing with TTBS, streptavidin-horseradish peroxidase (Southern Biotech, at 0.25 g/ml in 20% SuperBlock) was added to the wells for 1 h at room temperature. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "washing with TTBS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0441648:Washing [Activity]

Phrase: "streptavidin-horseradish peroxidase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   827   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0330510:Horseradish [Food]
   827   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   827   C1110641:Horseradish [Plant]
   827   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Southern Biotech,"

Phrase: "at 0.25 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "in 20% SuperBlock"

Phrase: ")"

Phrase: "was"

Phrase: "added to the wells"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1524062:Added [Functional Concept]
   737   C0205170:Well [Qualitative Concept]
   737 E C1883712:Add [Functional Concept]
   737   C3146287:Well [Manufactured Object]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.62: The fluorogenic substrate Amplex Ultra Red (Molecular Probes) was added to the plates and incubated for 15 min. 

Phrase: "The fluorogenic substrate Amplex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0016349:Fluorogenic Substrate [Indicator, Reagent, or Diagnostic Aid]

Phrase: "Ultra Red"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   944   C1532326:Infrared [Qualitative Concept]
   861   C0332575:Red [Finding]
   861   C0728475:ultra [Medical Device]
   861   C1260956:Red [Qualitative Concept]

Phrase: "(Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")"

Phrase: "was"

Phrase: "added to the plates"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1139930:plates [Medical Device]
   770   C1524062:Added [Functional Concept]
   737 E C0005971:Plate [Medical Device]
   737 E C1883712:Add [Functional Concept]
   737 E C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "incubated for 15 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]
Processing 00000000.tx.63: Reaction products were quantified using a Tecan Genios Pro plate reader at 535 nm excitation and 590 nm emission. 

Phrase: "Reaction products"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Tecan Genios Pro plate reader at 535 nm excitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1514743:Reader [Professional or Occupational Group]
   739   C1706461:Reader [Manufactured Object]

Phrase: "and"

Phrase: "590 nm emission."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0233929:Emission [Body Substance]
   827   C2349995:Emission [Substance]
Processing 00000000.tx.64: Enzymatic Activity AssaysFor neprilysin (NEP) activity assays, intact cells were incubated at 37 C for 2 h in Opti-MEM containing 50 M Suc-AAF-AMC in the absence or presence of 20 M thiorphan. 

Phrase: "Enzymatic Activity AssaysFor neprilysin (NEP) activity assays,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C2717977:Enzymatic Assays [Laboratory Procedure]
   766   C0005507:Assay [Laboratory Procedure]
   766   C0243073:assay [Qualitative Concept]
   766   C1510438:Assay [Laboratory Procedure]

Phrase: "intact cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in Opti-MEM"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50 M Suc-AAF-AMC in the absence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0763892:AAF-AMC [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "presence of 20 M thiorphan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.65: Cells were then homogenized, and protein concentrations were determined using a Bradford assay (Bio-Rad). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "homogenized"

Phrase: ","

Phrase: "and"

Phrase: "protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Bradford assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "(Bio-Rad"

Phrase: ")."
Processing 00000000.tx.66: Chymotrypsin-like activity of the endogenous proteasome was determined by solubilizing the cells in activity assay buffer (25 mM HEPES, pH 7.5, 0.5 mM EDTA, 0.05% Nonidet P-40, and 0.001% SDS). 

Phrase: "Chymotrypsin-like activity of the endogenous proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1150252:chymotrypsin activity [Molecular Function]
   774   C1622946:proteasome activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined by solubilizing"

Phrase: "the cells in activity assay buffer"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C0007634:THE CELL [Cell]
           Cells
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(25 mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "0.5 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "0.05% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   804   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   804   C0439509:/40 [Temporal Concept]

Phrase: "and"

Phrase: "0.001% SDS"

Phrase: ")."
Processing 00000000.tx.67: Cell extracts (40 g) were incubated at 37C for 2 h in 100 l of activity assay buffer containing 50 M Suc-LLVY-AMC in the absence or presence of 10 M of ALLN. 

Phrase: "Cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "(40 g)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1955160:40 g [Quantitative Concept]
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in 100 l"

Phrase: "of activity assay buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50 M Suc-LLVY-AMC"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of 10 M of ALLN."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.68: For purified proteasome activity assays, 12.5 g/ml purified human 20 S proteasome were incubated at 37 C for 2 h in 100 l of activity assay buffer containing 50 M Suc-LLVY-AMC. 

Phrase: "For purified proteasome activity assays,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C1622946:proteasome activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "12.5 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "human 20 S proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1325620:proteasome [Cell Component]
   812   C1752727:Proteasome [Molecular Function]

Phrase: "were"

Phrase: "incubated at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in 100 l"

Phrase: "of activity assay buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "50 M Suc-LLVY-AMC."
Processing 00000000.tx.69: Release of AMC was measured by fluorescence spectrophotometry using wavelengths of 340 nm excitation and 535 nm emission (Tecan Genios Pro). 

Phrase: "Release of AMC"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0030685:Release [Health Care Activity]
   790   C0391871:Release [Functional Concept]
   790   C0439180:% release [Quantitative Concept]
   790   C0680255:release [Health Care Activity]
   790   C1283071:Release [Functional Concept]
   790   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "measured by fluorescence spectrophotometry"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0242505:Fluorescence Spectrophotometry [Laboratory Procedure]
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0037805:Spectrophotometry [Laboratory Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "wavelengths of 340 nm excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449819:wavelengths [Quantitative Concept]

Phrase: "and"

Phrase: "535 nm emission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0233929:Emission [Body Substance]
   827   C2349995:Emission [Substance]

Phrase: "(Tecan Genios Pro"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2987124:PRO [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.70: Enzymatic activities were expressed as nmol AMC/min/mg protein. 

Phrase: "Enzymatic activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C2267219:Enzymatic Activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "expressed as nmol AMC/min/mg protein."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   804   C1881965:nmol/mg{protein} [Quantitative Concept]
   774   C0439291:nmol/mg [Quantitative Concept]
   774   C0439420:mg/min [Quantitative Concept]
   774   C2827910:nmol/min [Quantitative Concept]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439191:NMOLE [Quantitative Concept]
   748   C0439269:mg% [Quantitative Concept]
   748   C0702093:/min [Temporal Concept]
   748   C1960952:mg % [Quantitative Concept]
   748   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.71: View larger version (18K): [in this window] [in a new window]  FIGURE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 1."
Processing 00000000.tx.72: Structure of quercetin, catechin, and resveratrol.  

Phrase: "Structure of quercetin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0678594:Structure [Spatial Concept]

Phrase: "catechin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007404:Catechin [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "resveratrol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.73: View larger version (25K): [in this window] [in a new window]  FIGURE 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 2."
Processing 00000000.tx.74: Effect of resveratrol, quercetin, and catechin on A levels in APP695-HEK293 cells. 

Phrase: "Effect of resveratrol,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "quercetin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034392:Quercetin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "catechin on A levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007404:Catechin [Organic Chemical,Pharmacologic Substance]

Phrase: "in APP695-HEK293 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2936239:HEK293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.75: A and B, cells were treated for 24 h with the indicated concentrations of polyphenols (dissolved in Me2SO). 

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated for 24 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "with the indicated concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of polyphenols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0071649:polyphenols [Organic Chemical,Pharmacologic Substance]
   966 E C2348280:Polyphenol [Organic Chemical]

Phrase: "("

Phrase: "dissolved in Me2SO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1549535:Dissolve [Functional Concept]

Phrase: ")."
Processing 00000000.tx.76: Medium was changed, and drug treatments were continued for another 2 h to allow A secretion. 

Phrase: "Medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "drug treatments"
Meta Candidates (Total=11; Excluded=8; Pruned=0; Remaining=3)
   861   C0013227:Drug [Pharmacologic Substance]
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   861   C1254351:Drug [Pharmacologic Substance]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "were"

Phrase: "continued for another 2 h to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0011744:h 2 [Element, Ion, or Isotope]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0549178:Continued [Idea or Concept]
   753   C0564385:/h [Quantitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "A secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.77: Total sA was analyzed by ELISA (A) and WB (B, panel a). 

Phrase: "Total sA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "was"

Phrase: "analyzed by ELISA"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   783   C2717977:Enzyme Assay [Laboratory Procedure]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   753   C0243073:assay [Qualitative Concept]
   753   C0936012:Analyzed [Research Activity]
   753   C1510438:Assay [Laboratory Procedure]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "(A"

Phrase: ")"

Phrase: "and"

Phrase: "WB"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a"

Phrase: ")."
Processing 00000000.tx.78: B, sA40 (b), sA42 (c), and total intracellular A (panel d, total iA) were analyzed by IP and WB (see "Experimental Procedures"). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "sA40"

Phrase: "(b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "sA42"

Phrase: "(c),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "total intracellular A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(panel d,"

Phrase: "total iA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947960:Ia [Mammal]

Phrase: "were"

Phrase: "analyzed by IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]

Phrase: "and"

Phrase: "WB"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "(see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.79: Full-length APP (B, panel e) was analyzed by WB. 

Phrase: "Full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "panel e)"

Phrase: "was"

Phrase: "analyzed by WB."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.80: C, cells were treated for different periods of time with the indicated concentrations of resveratrol. 

Phrase: "C,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated for different periods of time"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   783   C0439582:Time periods [Temporal Concept]
   756 E C0585019:Temporal periods [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C1522326:Treated [Functional Concept]
   753   C1705242:Different [Qualitative Concept]
   753   C3541383:Time [Temporal Concept]
   748   C1442103:Time Difference [Temporal Concept]
   748   C1547049:*Time Difference [Quantitative Concept]
   719   C0439531:/period [Temporal Concept]
   719 E C1292734:TREAT [Functional Concept]
   719   C1948053:Period [Temporal Concept]

Phrase: "with the indicated concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of resveratrol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.81: Total sA was then analyzed as in B. 

Phrase: "Total sA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "as in B."
Processing 00000000.tx.82: The final concentration of Me2SO was adjusted to 0.04% (v/v) in all conditions. 

Phrase: "The final concentration of Me2SO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "adjusted to 0.04%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0456081:Adjusted [Functional Concept]

Phrase: "(v/v) in all conditions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0560268:%V/V [Quantitative Concept]
   806   C2349105:V(V) [Element, Ion, or Isotope]
Processing 00000000.tx.83: Histogram shows the mean  S.D. of 34 independent experiments. 

Phrase: "Histogram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348974:Histogram [Manufactured Object]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the mean  S.D."

Phrase: "of 34 independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.84: The Western blots shown are representative of at least three independent experiments.  

Phrase: "The Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.85: View larger version (42K): [in this window] [in a new window]  FIGURE 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 3."
Processing 00000000.tx.86: Effect of resveratrol on APP processing in N2a cells expressing wild type or Swedish APP695. 

Phrase: "Effect of resveratrol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "Swedish APP695."
Processing 00000000.tx.87: A, wild type APP695-N2a cells were treated for 24 h with increasing concentrations of resveratrol or with 1 M -secretase inhibitor, L-685,458 (first lane). 

Phrase: "A,"

Phrase: "wild type APP695-N2a cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C0449475:type cell [Intellectual Product]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated for 24 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "with increasing concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "or with 1"

Phrase: "M -"

Phrase: "secretase inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "L-685,458"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0915177:L-685,458 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0439394:l's [Quantitative Concept]
   827   C1706495:L- [Intellectual Product]
   827   C3642217:/L [Quantitative Concept]

Phrase: "(first lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.88: Medium was changed, and drug treatments were continued for another 2 h to allow A secretion. 

Phrase: "Medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "drug treatments"
Meta Candidates (Total=11; Excluded=8; Pruned=0; Remaining=3)
   861   C0013227:Drug [Pharmacologic Substance]
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   861   C1254351:Drug [Pharmacologic Substance]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "were"

Phrase: "continued for another 2 h to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0011744:h 2 [Element, Ion, or Isotope]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0549178:Continued [Idea or Concept]
   753   C0564385:/h [Quantitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "A secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.89: Total sA levels were then analyzed by WB (panel a). 

Phrase: "Total sA levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a"

Phrase: ")."
Processing 00000000.tx.90: APP C-terminal fragments, C99, C89, C83 (panel b, short film exposure; panel c, long film exposure) and APP intracellular domain (AICD, panel d) were analyzed by WB using R1 antibody. 

Phrase: "APP C-terminal fragments,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   841   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1168438:Protein C [Laboratory Procedure]
   827   C1418943:PROTEIN C [Gene or Genome]
   827   C1707271:C-Terminal [Amino Acid Sequence]
   827   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0205088:Terminal [Temporal Concept]
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   766 E C1708096:Fragment [Qualitative Concept]

Phrase: "C99,"

Phrase: "C89,"

Phrase: "C83"

Phrase: "(panel b,"

Phrase: "short film exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]

Phrase: "; panel c,"

Phrase: "long film exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "APP intracellular domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C0162808:Protein Domain [Spatial Concept]
   853   C1514562:Protein Domain [Amino Acid Sequence]
   804   C0175996:intracellular [Cell Component]
   804   C0178719:Intracellular [Spatial Concept]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(AICD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "d)"

Phrase: "were"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "R1 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.91: Full-length APP (panel e) and secreted APP (sAPP, panel f) were probed with antibodies 22C11 and 6E10, respectively. 

Phrase: "Full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "(panel e)"

Phrase: "and"

Phrase: "secreted APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1327616:Secreted [Cell Function]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "(sAPP,"

Phrase: "panel f)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "were"

Phrase: "probed with antibodies 22C11"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "6E10,"

Phrase: "respectively."
Processing 00000000.tx.92: B, Swedish APP695-N2a cells were treated with resveratrol or L-685,458 as described in A. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Swedish APP695-N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with resveratrol"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "L-685,458"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0915177:L-685,458 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0439394:l's [Quantitative Concept]
   827   C1706495:L- [Intellectual Product]
   827   C3642217:/L [Quantitative Concept]

Phrase: "as"

Phrase: "described in A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0011560:Amyloid [Pathologic Function]
   790   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.93: Total sA was then analyzed as above. 

Phrase: "Total sA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed as above."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.94: The Western blots shown are representative of at least three independent experiments.  

Phrase: "The Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.95: In Vitro -Secretase AssaysIn vitro assays were performed as described previously (15). 

Phrase: "In Vitro -Secretase AssaysIn vitro assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   887   C1515653:In Vitro Assay [Research Activity]
   766   C0005507:Assay [Laboratory Procedure]
   766   C0243073:assay [Qualitative Concept]
   766   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.96: Briefly, cells were resuspended in 0.5 ml/35-mm dish of hypotonic buffer (10 mM MOPS, pH 7.0, 10 mM KCl) and homogenized on ice. 

Phrase: "Briefly,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "resuspended in 0.5 ml/35-mm dish of hypotonic buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0444499:0/5 [Quantitative Concept]
   738   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   738   C0020498:DISH [Disease or Syndrome]
   738   C0241938:Hypotonic [Pathologic Function]
   738   C0439526:/mL [Quantitative Concept]

Phrase: "(10 mM MOPS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0066823:MOPS [Organic Chemical]
   827   C1271466:Mops [Mammal]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "10 mM KCl"

Phrase: ")"

Phrase: "and"

Phrase: "homogenized on ice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020746:Ice [Inorganic Chemical]
Processing 00000000.tx.97: A postnuclear supernatant was prepared by centrifugation at 1000 x g for 15 min at 4 C. 

Phrase: "A postnuclear supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "prepared by centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C1521827:Prepare [Functional Concept]

Phrase: "at 1000 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C."
Processing 00000000.tx.98: Crude membranes were isolated from the postnuclear supernatant by centrifugation at 16,000 x g for 40 min at 4 C. 

Phrase: "Crude membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "isolated from the postnuclear supernatant"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C1550101:Supernatant [Body Substance]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "by centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 16,000 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "for 40 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C."
Processing 00000000.tx.99: The membranes were then resuspended in 25 lof assay buffer (150 mM sodium citrate, pH 6.4, 1x Complete) and incubated at 37 C for 4 h in the absence or presence of the indicated drugs. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "resuspended in 25 lof"

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(150 mM sodium citrate,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0142825:sodium citrate [Organic Chemical,Pharmacologic Substance]
   812   C0008857:Citrate [Organic Chemical]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "pH 6.4,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C2678549:PH-4 [Gene or Genome]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1x"

Phrase: "Complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "incubated at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of the indicated drugs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0428261:Presence of drug [Laboratory or Test Result]
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.100: Samples were then analyzed by WB.  

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by WB."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.101: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Because evidence is increasing that moderate wine intake reduces the risk of developing AD (710), we sought to determine whether three powerful antioxidant polyphenols found in red wine, resveratrol (trans-3,4',5-trihydroxystilbene, see Fig. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   758   C1514811:Reference [Idea or Concept]
   758   C1706462:Reference [Conceptual Entity]

Phrase: "Because"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "that moderate wine intake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0559432:Wine intake [Finding]
   827   C1512806:Intake [Functional Concept]

Phrase: "reduces"

Phrase: "the risk of developing AD (710"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0035647:Risk [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "three powerful antioxidant polyphenols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0071649:polyphenols [Organic Chemical,Pharmacologic Substance]
   779 E C2348280:Polyphenol [Organic Chemical]

Phrase: "found in red wine,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0349371:Red wine [Food]
   770   C0043188:Wine [Food]
   770   C0150312:Found [Quantitative Concept]
   770   C0332575:Red [Finding]
   770   C1260956:Red [Qualitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "(trans-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2826298:TRANS [Idea or Concept]

Phrase: "4',"

Phrase: "5-trihydroxystilbene,"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.102: 1), quercetin (3,3',4',5,7-pentahydroxyflavone), and catechin ((+)-trans-3,3',4',5,7-pentahydroxyflavane), modulate A levels. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "quercetin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034392:Quercetin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4',"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7-pentahydroxyflavone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0603715:pentahydroxyflavone [Organic Chemical]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "catechin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007404:Catechin [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "(+"

Phrase: ")-"

Phrase: "trans-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2826298:TRANS [Idea or Concept]

Phrase: "3',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4',"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7-pentahydroxyflavane"

Phrase: ")"

Phrase: ","

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "A levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.103: To this end, we treated APP695-transfected HEK293 cells with increasing concentrations of the different polyphenols and analyzed A levels by ELISA and WB. 

Phrase: "To this end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "we"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "APP695-transfected HEK293 cells with increasing concentrations of the different polyphenols"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   756   C2936239:HEK293 Cells [Cell]
   738   C0007634:Cells [Cell]
   738   C3282337:Cells [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "analyzed A levels by ELISA"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0014440:enzyme levels [Laboratory Procedure]
   767   C1287349:enzyme levels [Laboratory or Test Result]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "WB."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.104: Total secreted A (Fig. 2, A and B, panel a), including secreted A40 (Fig. 2B, panel b) and A42 (Fig. 2B, panel c), were markedly reduced by 2040 M resveratrol after 24 h of incubation, whereas quercetin and catechin were apparently ineffective at these concentrations (Fig. 2, A and B, panel a). 

Phrase: "Total secreted A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a"

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "secreted A40"

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "A42"

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "c),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "were"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "reduced by 2040 M resveratrol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0392756:Reduced [Qualitative Concept]
   760   C0441923:M+ [Intellectual Product]

Phrase: "after 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of incubation,"

Phrase: "whereas"

Phrase: "quercetin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034392:Quercetin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "catechin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007404:Catechin [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "apparently ineffective at these concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3242229:ineffective [Idea or Concept]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a"

Phrase: ")."
Processing 00000000.tx.105: At the same concentration range, resveratrol also reduced total intracellular A (Fig. 2B, panel d). 

Phrase: "At the same concentration range,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   827   C1514721:Range [Quantitative Concept]
   827   C2348147:Range [Quantitative Concept]
   827   C3542016:Range [Intellectual Product]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "resveratrol also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "total intracellular A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "d)."
Processing 00000000.tx.106: Because resveratrol treatment did not lead to intracellular accumulation of A (Fig. 2B, panel d), we concluded that A secretion was not impaired. 

Phrase: "Because"

Phrase: "resveratrol treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "lead to intracellular accumulation of A"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0175996:intracellular [Cell Component]
   753   C0178719:Intracellular [Spatial Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "d)"

Phrase: ","

Phrase: "we"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that A secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "impaired."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]
Processing 00000000.tx.107: To determine whether the effect of resveratrol is time-dependent, APP695-HEK293 cells were then treated for different periods of time with 10 or 20 M polyphenol. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the effect of resveratrol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "time-dependent, APP695-HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C2936239:HEK293 Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated for different periods of time"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   783   C0439582:Time periods [Temporal Concept]
   756 E C0585019:Temporal periods [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C1522326:Treated [Functional Concept]
   753   C1705242:Different [Qualitative Concept]
   753   C3541383:Time [Temporal Concept]
   748   C1442103:Time Difference [Temporal Concept]
   748   C1547049:*Time Difference [Quantitative Concept]
   719   C0439531:/period [Temporal Concept]
   719 E C1292734:TREAT [Functional Concept]
   719   C1948053:Period [Temporal Concept]

Phrase: "with 10"

Phrase: "or"

Phrase: "20 M polyphenol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0071649:Polyphenol [Organic Chemical,Pharmacologic Substance]
   827   C2348280:Polyphenol [Organic Chemical]
Processing 00000000.tx.108: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.109: 2C shows that, although resveratrol did not affect A levels after 12 h of incubation, its inhibitory effect on A levels is gradually strengthened after longer incubation periods of 48 and 72 h. 

Phrase: "2C"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "although"

Phrase: "resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "A levels after 12 h of incubation,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "its inhibitory effect on A levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "gradually"

Phrase: "strengthened after longer incubation periods of 48"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1320226:incubation periods [Finding]
   772   C0425943:Length of periods [Finding]
           period length
   714   C0205166:Long [Qualitative Concept]
   714   C0439531:/period [Temporal Concept]
   714   C1706317:Long [Qualitative Concept]
   714   C1948053:Period [Temporal Concept]

Phrase: "and"

Phrase: "72 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.110: View larger version (34K): [in this window] [in a new window]  FIGURE 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 4."
Processing 00000000.tx.111: Resveratrol does not affect-secretase activity in vitro. 

Phrase: "Resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "secretase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.112: Panel a, membrane preparations from APP695-HEK293 cells (see "Experimental Procedures") were incubated in vitro at 4 C (lane 1) or 37C (lanes 27) for 4 h in the absence or presence of the indicated drugs. 

Phrase: "Panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a,"

Phrase: "membrane preparations from APP695-HEK293 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C0920433:cell preparation [Laboratory Procedure]
   719   C0455052:Preparation [Health Care Activity]
   719   C1521827:Preparation [Functional Concept]

Phrase: "(see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "in vitro at 4 C (lane 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "37C"

Phrase: "(lanes 27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "for 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of the indicated drugs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0428261:Presence of drug [Laboratory or Test Result]
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.113: Total A produced in vitro was analyzed by WB with 6E10 antibody. 

Phrase: "Total A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "produced"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "was"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with 6E10 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.114: Panels b and c, membranes from APP695-HEK293 cells treated in culture for 24 h in the absence or presence of the indicated drugs were incubated as described above. 

Phrase: "Panels b"

Phrase: "and"

Phrase: "c,"

Phrase: "membranes from APP695-HEK293 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   781   C0007603:Cell membranes [Cell Component]
   764 E C3161472:Cell Membrane [Cell Component]
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "treated in culture"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0010453:Culture [Idea or Concept]
   790   C0220814:culture [Functional Concept]
   790   C0332293:treated [Therapeutic or Preventive Procedure]
   790   C0430400:Culture [Laboratory Procedure]
   790   C1522326:Treated [Functional Concept]
   790   C2242979:Culture [Laboratory Procedure]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of the indicated drugs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0428261:Presence of drug [Laboratory or Test Result]
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "incubated as described above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1552738:described [Idea or Concept]
Processing 00000000.tx.115: Total A and N-cadherin-derived C-terminal fragments (N-Cad/CTF1 and N-Cad/CTF2) were analyzed by WB with antibodies 6E10 (panel b) and C32 (panel c), respectively.  

Phrase: "Total A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "N-cadherin-derived C-terminal fragments"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   858   C2349138:N/C [Quantitative Concept]
   827   C1707271:C-Terminal [Amino Acid Sequence]
   799   C0205088:Terminal [Temporal Concept]
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   766 E C1708096:Fragment [Qualitative Concept]

Phrase: "(N-Cad/CTF1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0294361:CTF1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1332801:CTF1 [Gene or Genome]

Phrase: "and"

Phrase: "N-Cad/CTF2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1428360:CTF2 [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with antibodies 6E10"

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C32"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1421906:C32 [Gene or Genome]
  1000   C2700320:C32 [Fish]

Phrase: "(panel c), respectively."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.116: To exclude a cell line-specific effect, we also treated APP695-transfected mouse neuroblastoma N2a cells with resveratrol. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "a cell line-specific effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1280500:Effect [Qualitative Concept]
   804   C2348382:Effect [Qualitative Concept]

Phrase: "we also treated APP695-transfected mouse neuroblastoma N2a cells with resveratrol."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   738   C0007634:Cells [Cell]
   738   C3282337:Cells [Cell]
   737   C0815000:neuroblastoma cell [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.117: This showed that resveratrol inhibited total secreted A at the same concentration range in another cell line (Fig. 3A, panel a). 

Phrase: "This"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "total secreted A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "at the same concentration range"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   827   C1514721:Range [Quantitative Concept]
   827   C2348147:Range [Quantitative Concept]
   827   C3542016:Range [Intellectual Product]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in another cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007600:Cell Line [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:Line [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3A,"

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a"

Phrase: ")."
Processing 00000000.tx.118: Secreted A produced by N2a cells overexpressing APP695 bearing the familial AD Swedish mutation, was also reduced by similar treatments (Fig. 3B). 

Phrase: "Secreted A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "produced by N2a cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0445079:N2a [Finding]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "APP695"

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the familial AD Swedish mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "also"

Phrase: "reduced by similar treatments"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0087111:Treatments [Therapeutic or Preventive Procedure]
   770   C0392756:Reduced [Qualitative Concept]
   770   C2348205:Similar [Qualitative Concept]
   737 E C0039798:treatment [Functional Concept]
   737 E C1522326:Treatment [Functional Concept]
   737 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   737 E C1705169:Treatment [Conceptual Entity]
   737 E C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.119: To determine whether resveratrol affects APP metabolism, we then monitored by WB the levels of APP holoprotein and proteolytic fragments. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "APP metabolism,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1327340:amyloid precursor protein metabolism [Molecular Function]
   861   C0597299:Protein Metabolism [Molecular Function]
   812   C0025519:Metabolism [Organism Function]
   812   C0025520:metabolism [Functional Concept]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "we then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "monitored by WB"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "the levels of APP holoprotein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "proteolytic fragments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.120: At the same concentrations, resveratrol neither affected full-length APP levels (Fig. 2B, panel e, and Fig. 3A, panel e) nor reduced secreted APP immunoreactivity (Fig. 3A, panel f). 

Phrase: "At the same concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "neither affected full-length APP levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   795   C0441889:Levels [Qualitative Concept]
   785   C0428479:Protein level [Laboratory or Test Result]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "panel e,"

Phrase: "and"

Phrase: "Fig. 3A,"

Phrase: "panel e)"

Phrase: "nor"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "secreted APP immunoreactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0597879:immunoreactivity [Molecular Function]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(Fig. 3A,"

Phrase: "panel f)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.121: In addition, resveratrol did not affect the steady-state levels of APP C-terminal fragments C99, C89, and C83 (Fig. 3A, panels b and c) and APP intracellular domain (AICD, Fig. 3A, panel d). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the steady-state levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0678587:steady state [Natural Phenomenon or Process]
   884   C0683927:state level [Spatial Concept]
   827   C0205361:Steady [Qualitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "of APP C-terminal fragments C99,"

Phrase: "C89,"

Phrase: "and"

Phrase: "C83"

Phrase: "(Fig. 3A,"

Phrase: "panels b"

Phrase: "and"

Phrase: "c)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "APP intracellular domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C0162808:Protein Domain [Spatial Concept]
   853   C1514562:Protein Domain [Amino Acid Sequence]
   804   C0175996:intracellular [Cell Component]
   804   C0178719:Intracellular [Spatial Concept]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(AICD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "Fig. 3A,"

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "d)."
Processing 00000000.tx.122: Together these data indicate that resveratrol had no effect on the -, -, or -secretase-mediated cleavages of APP or on the stability of APP or its C-terminal fragments. 

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "had"

Phrase: "no effect on the -, -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: ","

Phrase: "or -secretase-mediated cleavages of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C0597304:Protein Cleavage [Molecular Function]
   711   C0010813:cleavage [Cell Function]
   711   C0596311:Cleavage [Phenomenon or Process]
   711   C1330957:cleavage [Cell Function]

Phrase: "or on the stability of APP"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C2350440:Protein Stability [Qualitative Concept]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205360:Stability [Qualitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
   744   C2347098:Stability [Qualitative Concept]

Phrase: "or"

Phrase: "its C-terminal fragments."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.123: Therefore, resveratrol did not affect APP metabolism and A production. 

Phrase: "Therefore,"

Phrase: "resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "APP metabolism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1327340:amyloid precursor protein metabolism [Molecular Function]
   861   C0597299:Protein Metabolism [Molecular Function]
   812   C0025519:Metabolism [Organism Function]
   812   C0025520:metabolism [Functional Concept]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]
Processing 00000000.tx.124: To confirm that resveratrol did not inhibit -or -secretase directly, resveratrol was used in a cell-free assay designed to produce A in vitro. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit -"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "or -secretase directly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "used in a cell-free assay"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   790   C1183428:cell free [Cell]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0007634:Cell [Cell]
   753   C0243073:assay [Qualitative Concept]
   753   C0332296:free [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1273517:used [Finding]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1704653:Cell [Medical Device]
   753   C1880497:Free [Qualitative Concept]
   753   C1948049:Cell [Spatial Concept]
   753   C1996904:Free [Qualitative Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "A in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.125: In this in vitro assay, membrane preparations isolated from APP695-HEK293 cells were incubated at 37 C for 4 h in the absence or presence of increasing concentrations of resveratrol. 

Phrase: "In this in vitro assay,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1515653:In Vitro Assay [Research Activity]
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "membrane preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "isolated from APP695-HEK293 cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   806   C2936239:HEK293 Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C0370215:Isolate [Substance]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 4 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of increasing concentrations of resveratrol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.126: Production of A was not affected by the presence of resveratrol in vitro (Fig. 4a). 

Phrase: "Production of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by the presence of resveratrol"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0392760:Affected [Functional Concept]
   753   C1314939:Affected [Functional Concept]
   719 E C0001721:Affect [Mental Process]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(Fig. 4a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.127: However, the levels of A produced in vitro by membranes isolated from cells treated in culture with the polyphenol were significantly reduced (Fig. 4b), indicating that resveratrol promoted A reduction without directly affecting - and -secretases. 

Phrase: "However,"

Phrase: "the levels of A produced in vitro"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "by membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "isolated from cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   790   C0007634:Cells [Cell]
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   790   C3282337:Cells [Cell]
   756 E C0370215:Isolate [Substance]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1875400:ISOLATE [Pharmacologic Substance]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "treated in culture"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0010453:Culture [Idea or Concept]
   790   C0220814:culture [Functional Concept]
   790   C0332293:treated [Therapeutic or Preventive Procedure]
   790   C0430400:Culture [Laboratory Procedure]
   790   C1522326:Treated [Functional Concept]
   790   C2242979:Culture [Laboratory Procedure]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "with the polyphenol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0071649:Polyphenol [Organic Chemical,Pharmacologic Substance]
  1000   C2348280:Polyphenol [Organic Chemical]

Phrase: "were"

Phrase: "significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(Fig. 4b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that resveratrol promoted A reduction without directly affecting -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and -"

Phrase: "secretases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.128: View larger version (27K): [in this window] [in a new window]  FIGURE 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 5."
Processing 00000000.tx.129: Proteasome inhibition prevents the resveratrol-mediated decrease of A. 

Phrase: "Proteasome inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the resveratrol-mediated decrease of A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.130: A, APP695-HEK293 cells were incubated for 24 h with increasing concentrations of resveratrol. 

Phrase: "A,"

Phrase: "APP695-HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2936239:HEK293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 24 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with increasing concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of resveratrol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.131: Thiorphan-sensitive endoproteolytic activity (NEP Activity) was then determined on intact cells as described under "Experimental Procedures." 

Phrase: "Thiorphan-sensitive endoproteolytic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "(NEP Activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150197:neprilysin activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "determined on intact cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   816   C0682538:intact cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0205266:Intact [Qualitative Concept]
   770   C1554187:Intact [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.132: B, APP695-HEK293 cells were treated for 24 h with resveratrol (40 M) or its vehicle (dimethyl sulfoxide, DMSO) in the absence (Control) or presence of phosphoramidon (50 M), thiorphan (20 M), insulin (10 M), lactacystin (2 M), Z-GPFL-CHO (25 M), or YU101 (1 M). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "APP695-HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2936239:HEK293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated for 24 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "with resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "M)"

Phrase: "or"

Phrase: "its vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "(dimethyl sulfoxide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012403:Dimethyl Sulfoxide [Organic Chemical,Pharmacologic Substance]
   861   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0038771:sulfoxide [Organic Chemical]
   861   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "DMSO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "presence of phosphoramidon"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "(50"

Phrase: "M)"

Phrase: ","

Phrase: "thiorphan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039945:Thiorphan [Organic Chemical,Pharmacologic Substance]

Phrase: "(20"

Phrase: "M)"

Phrase: ","

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10"

Phrase: "M)"

Phrase: ","

Phrase: "lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "M)"

Phrase: ","

Phrase: "Z-GPFL-CHO (25"

Phrase: "M)"

Phrase: ","

Phrase: "or"

Phrase: "YU101"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1565728:YU101 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "M)."
Processing 00000000.tx.133: Total sA was then analyzed by ELISA as described in Fig. 

Phrase: "Total sA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by ELISA"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   783   C2717977:Enzyme Assay [Laboratory Procedure]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   753   C0243073:assay [Qualitative Concept]
   753   C0936012:Analyzed [Research Activity]
   753   C1510438:Assay [Laboratory Procedure]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.134: 2A. 

Phrase: "2A."
Processing 00000000.tx.135: C, APP695-HEK293 cells transfected with 5 siRNAs or buffer only (Control) were treated for 24 h with resveratrol (40 M) or its vehicle (dimethyl sulfoxide, DMSO). 

Phrase: "C,"

Phrase: "APP695-HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2936239:HEK293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with 5 siRNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1099354:siRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "buffer only"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "treated for 24 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "with resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "M)"

Phrase: "or"

Phrase: "its vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "(dimethyl sulfoxide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012403:Dimethyl Sulfoxide [Organic Chemical,Pharmacologic Substance]
   861   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0038771:sulfoxide [Organic Chemical]
   861   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "DMSO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.136: Cells were then harvested and analyzed by WB with anti-5 antibody (panel a) and with anti--tubulin antibody (panel c). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-5 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a)"

Phrase: "and with anti--tubulin antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1515981:And [Idea or Concept]
   760   C2937342:tubulin [Cell Component]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "c)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.137: Total sA (panel b) was analyzed by WB as described in Fig. 

Phrase: "Total sA (panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: "b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "was"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.138: 2B. 

Phrase: "2B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450354:2b [Intellectual Product]
  1000   C1706096:2B [Research Activity]
Processing 00000000.tx.139: ALLN-sensitive endoproteolytic activity (proteasome activity) was determined as described under "Experimental Procedures." 

Phrase: "ALLN-sensitive endoproteolytic activity"

Phrase: "(proteasome activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1622946:proteasome activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "determined"

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.140: D, purified human 20 S proteasome was incubated for 30 min with lactacystin (20 M), dimethyl sulfoxide, or resveratrol (40 M). 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "purified human 20 S proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1325620:proteasome [Cell Component]
   804   C1752727:Proteasome [Molecular Function]

Phrase: "was"

Phrase: "incubated for 30 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "(20"

Phrase: "M)"

Phrase: ","

Phrase: "dimethyl sulfoxide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012403:Dimethyl Sulfoxide [Organic Chemical,Pharmacologic Substance]
   861   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0038771:sulfoxide [Organic Chemical]
   861   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "M)."
Processing 00000000.tx.141: Proteasome activity was then monitored as in C. 

Phrase: "Proteasome activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1622946:proteasome activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "as in C."
Processing 00000000.tx.142: E, APP695-HEK293 cells were treated for 24 h with dimethyl sulfoxide or resveratrol (40 M). 

Phrase: "E,"

Phrase: "APP695-HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2936239:HEK293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated for 24 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "with dimethyl sulfoxide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012403:Dimethyl Sulfoxide [Organic Chemical,Pharmacologic Substance]
   861   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0038771:sulfoxide [Organic Chemical]
   861   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "M)."
Processing 00000000.tx.143: Cells were then harvested and analyzed by WB with anti-20 S proteasome subunits / antibody (panel a) and with anti--catenin antibody (panel b). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-20 S proteasome subunits / antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   895   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a)"

Phrase: "and with anti"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "--"

Phrase: "catenin antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(panel b"

Phrase: ")."
Processing 00000000.tx.144: Five hundred nanograms of purified human 20 S proteasome were analyzed by WB (panel a, last lane). 

Phrase: "Five hundred nanograms of purified human 20 S proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439212:nanograms [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a,"

Phrase: "last lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.145: Values are the mean  S.D. of 35 independent experiments. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "the mean  S.D."

Phrase: "of 35 independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.146: *, p < 0.05; 

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.147: **, p < 0.01 (Student's t test).  

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "(Student's t test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.148: -Secretase targets several other type I proteins, including the cell-cell adhesion receptors E- and N-cadherins (15, 16). 

Phrase: "-Secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "other type I proteins,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0441729:Type I [Classification]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the cell-cell adhesion receptors E-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C1154382:cell-cell adhesion [Cell Function]

Phrase: "and"

Phrase: "N-cadherins"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0027215:N-Cadherins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   983 E C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827 E C1413274:cadherin [Gene or Genome]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.149: Cleavage of N-cadherin by -secretase produces the transcriptionally active intracellular fragment N-Cad/CTF2 from the proteolytic cleavage of the intermediate C-terminal fragment N-Cad/CTF1 (15). 

Phrase: "Cleavage of N-cadherin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "by -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "produces"

Phrase: "the transcriptionally active intracellular fragment N-Cad/CTF2 from the proteolytic cleavage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1428360:CTF2 [Gene or Genome]

Phrase: "of the intermediate C-terminal fragment N-Cad/CTF1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0294361:CTF1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C1332801:CTF1 [Gene or Genome]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.150: Using a similar cell-free assay we determined that production of N-Cad/CTF2 was not affected by resveratrol treatment (Fig. 4c), confirming the absence of inhibitory effect of resveratrol on -secretase activity. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a similar cell-free assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "we"

Phrase: "determined"

Phrase: "that production of N-Cad/CTF2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by resveratrol treatment"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0039798:treatment [Functional Concept]
   770   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C0001721:Affect [Mental Process]

Phrase: "(Fig. 4c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the absence of inhibitory effect of resveratrol on -secretase activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0332197:absence [Quantitative Concept]
   739   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.151: Together with the observation that resveratrol did not affect the levels of APP holoprotein and its C-terminal proteolytic fragments, these data indicate that resveratrol did not target an A-producing activity but rather promoted A clearance. 

Phrase: "Together with the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the levels of APP holoprotein"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "its C-terminal proteolytic fragments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "an A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "producing activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "but"

Phrase: "rather promoted A clearance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0449297:Clearance [Qualitative Concept]
   812   C1382187:Clearance [Clinical Attribute]
   812   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.152: Based on these observations, we aimed to determine whether resveratrol treatment promotes A degradation. 

Phrase: "Based on these observations,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0302523:observations [Research Activity]
   770   C0700325:observations [Health Care Activity]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C3244290:observations [Functional Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
   737 E C1964257:Observation [Diagnostic Procedure]

Phrase: "we"

Phrase: "aimed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C1947946:Aim [Idea or Concept]
   966   C2948600:Aim [Pharmacologic Substance]
   966   C3540471:AIM [Gene or Genome]
   966   C3540472:AIM [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "resveratrol treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "A degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.153: A peptides are degraded in vivo by at least four metalloendopeptidases, NEP, endothelin-converting enzyme-1 and -2 (ECE-1 and -2), and insulin-degrading enzyme (IDE) (17). 

Phrase: "A peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "in vivo by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "at least four metalloendopeptidases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1442934:Metalloendopeptidases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "endothelin-converting enzyme-1 and -2 (ECE-1 and -2),"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   919   C1421917:ENDOTHELIN-CONVERTING ENZYME 2 [Gene or Genome]
   919   C1567265:Endothelin-converting enzyme 2 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0246118:Endothelin-converting enzyme 1 [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1414244:ENDOTHELIN-CONVERTING ENZYME 1 [Gene or Genome]
   895   C0079282:Endothelin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   895   C1333329:ENDOTHELIN 2 [Gene or Genome]
   861   C2745878:endothelin-converting enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   858   C0079281:Endothelin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   858   C1414260:ENDOTHELIN 1 [Gene or Genome]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "insulin-degrading enzyme (IDE)"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.154: Recent evidence indicates that long term treatment with resveratrol promotes NEP activity in SK-N-SH cells (18). 

Phrase: "Recent evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that long term treatment with resveratrol"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0023977:long-term treatment [Health Care Activity]
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "NEP activity in SK-N-SH cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1150197:neprilysin activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.155: Using thiorphan-sensitive enzymatic assays on intact HEK293 cells, we confirmed that NEP activity was significantly increased upon resveratrol treatment (Fig. 5A). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "thiorphan-sensitive enzymatic assays on intact HEK293 cells,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C2717977:Enzymatic Assays [Laboratory Procedure]
   711   C0005507:Assay [Laboratory Procedure]
   711   C0243073:assay [Qualitative Concept]
   711   C1510438:Assay [Laboratory Procedure]

Phrase: "we"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that NEP activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150197:neprilysin activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "increased upon resveratrol treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0039798:treatment [Functional Concept]
   770   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.156: However, inhibition of NEP with phosphoramidon or thiorphan in APP695-HEK293 cells could not prevent the decrease of A levels triggered by resveratrol (Fig. 5B). 

Phrase: "However,"

Phrase: "inhibition of NEP"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "with phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "or"

Phrase: "thiorphan in APP695-HEK293 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0039945:Thiorphan [Organic Chemical,Pharmacologic Substance]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the decrease of A levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "triggered by resveratrol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C1444748:Triggered by [Qualitative Concept]
           Trigger
   790   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]
   756   C0032930:Trigger [Clinical Attribute]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.157: Because phosphoramidon also inhibits ECE-1 and -2, we concluded that these enzymatic activities were also not involved in the resveratrol-mediated decrease of A. 

Phrase: "Because"

Phrase: "phosphoramidon also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "ECE-1 and -2,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "we"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "these enzymatic activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C2267219:Enzymatic Activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "also"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved in the resveratrol-mediated decrease of A."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1314939:Involved [Functional Concept]
Processing 00000000.tx.158: Further, pretreatment with insulin, which acts as a competitive inhibitor of IDE, did not rescue A levels during resveratrol treatment (Fig. 5B). 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "pretreatment with insulin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "which"

Phrase: "acts as a competitive inhibitor of IDE,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   762   C0014432:Enzyme inhibitor [Pharmacologic Substance]
   762   C0021643:insulin inhibitor [Pharmacologic Substance]
   762   C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0079613:ACT [Therapeutic or Preventive Procedure]
   742   C0679932:competitive [Social Behavior]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1999216:Inhibitor [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "rescue"

Phrase: "A levels during resveratrol treatment"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.159: Thus, resveratrol did not promote A degradation by NEP, ECE-1 and -2, or IDE in HEK293 cells. 

Phrase: "Thus,"

Phrase: "resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "A degradation by NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "ECE-1 and -2,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "or"

Phrase: "IDE in HEK293 cells."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   767   C0030281:Insulin Cell [Cell]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.160: Converging evidence indicates that resveratrol promotes the proteasomal degradation of a specific subset of proteins, including cyclin D1 (19), the estrogen receptor- (20), or the hypoxia-inducible factor-1 (21). 

Phrase: "Converging evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the proteasomal degradation of a specific subset of proteins,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   745   C0597297:Protein Degradation [Molecular Function]
   745   C0597304:Protein Degradation [Molecular Function]
   745   C1623036:Protein Degradation [Molecular Function]
   742   C0243125:degradation [Functional Concept]
   742   C0699900:Degradation [Organism Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cyclin D1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0174680:Cyclin D1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1150565:cyclin [Molecular Function]
   861   C1416886:D1 [Gene or Genome]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "the estrogen receptor-"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0034804:Estrogen receptor [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414461:ESTROGEN RECEPTOR [Gene or Genome]
  1000   C1521863:Estrogen Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0014939:Estrogen [Hormone,Pharmacologic Substance,Steroid]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C2936882:Estrogen [Pharmacologic Substance]
   789 E C0720298:Estrogenic [Hormone,Organic Chemical,Pharmacologic Substance]

Phrase: "(20"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "the hypoxia-inducible factor-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0215848:Hypoxia-Inducible Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0205263:Inducible [Functional Concept]
   812   C0242184:Hypoxia [Pathologic Function]
   812   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1521761:Factor [Functional Concept]
   812   C1963140:HYPOXIA [Finding]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.161: Because the proteasome has been shown to modulate A levels (22), we asked whether proteasome inhibition rescues A levels upon resveratrol treatment. 

Phrase: "Because"

Phrase: "the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "asked"

Phrase: "whether"

Phrase: "proteasome inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "rescues"

Phrase: "A levels upon resveratrol treatment."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.162: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.163: 5B shows that treatments with the selective proteasome inhibitors, lactacystin, Z-GPFL-CHO, or YU101, significantly prevented the resveratrol-induced decrease of A. 

Phrase: "5B"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that treatments with the selective proteasome inhibitors,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   748   C0087111:Treatments [Therapeutic or Preventive Procedure]
   714 E C0039798:treatment [Functional Concept]
   714 E C1522326:Treatment [Functional Concept]
   714 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   714 E C1705169:Treatment [Conceptual Entity]
   714 E C3538994:TREATMENT [Research Activity]

Phrase: "lactacystin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "Z-GPFL-CHO,"

Phrase: "or"

Phrase: "YU101,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1565728:YU101 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "significantly"

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the resveratrol-induced decrease of A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.164: To confirm the involvement of the proteasome in the anti-amyloidogenic effect of resveratrol, we sought to down-regulate proteasome activity by siRNA-directed silencing. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the involvement of the proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "in the anti-amyloidogenic effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "of resveratrol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "down-regulate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "proteasome activity by siRNA-directed silencing."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1622946:proteasome activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.165: The proteasome is a multicatalytic protease complex formed by different subunits encoded by several genes (23). 

Phrase: "The proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "is"

Phrase: "a multicatalytic protease complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "formed by different subunits"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0205431:Formed [Functional Concept]
   770   C1705242:Different [Qualitative Concept]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]
   737   C1711351:Subunit [Quantitative Concept]

Phrase: "encoded by several genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017337:Genes [Gene or Genome]
   770   C0679058:encoded [Mental Process]
   770   C2700640:Encoded [Activity]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.166: Because YU101 is highly selective for the chymotrypsin-like activity of the proteasome (24) and because the subunit 5 is critical for this proteolytic activity (23), we asked whether siRNA-directed silencing of the proteasome subunit 5 prevents the resveratrol-induced decrease of A. 

Phrase: "Because"

Phrase: "YU101"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1565728:YU101 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "is"

Phrase: "highly selective for the chymotrypsin-like activity of the proteasome"

Phrase: "(24"

Phrase: ")"

Phrase: "and"

Phrase: "because"

Phrase: "the subunit 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "critical for this proteolytic activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511545:Critical [Qualitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "asked"

Phrase: "whether"

Phrase: "siRNA-directed silencing of the proteasome subunit 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the resveratrol-induced decrease of A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.167: Transfection of siRNAs directed against the subunit 5 strongly decreased 5 protein expression (Fig. 5C, panel a) and inhibited more than 60% of the chymotrypsin-like activity of the proteasome (Fig. 5C). 

Phrase: "Transfection of siRNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "directed against the subunit 5 strongly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1711351:Subunit [Quantitative Concept]
   719   C0439851:Direct [Qualitative Concept]
   719   C1947931:Direct [Qualitative Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "5 protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1171362:protein expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 5C,"

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a)"

Phrase: "and"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "more than 60% of the chymotrypsin-like activity of the proteasome"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   756   C1413809:chymotrypsin-like [Gene or Genome]
   754   C1150252:chymotrypsin activity [Molecular Function]
   754   C1622946:proteasome activity [Molecular Function]
   738   C0008742:CHYMOTRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   738   C0205172:More [Functional Concept]
   738   C0205177:Activity [Functional Concept]
   738   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0439167:% activity [Quantitative Concept]
   738   C0441655:Activity [Activity]
   738   C1325620:proteasome [Cell Component]
   738   C1561536:*Activity [Idea or Concept]
   738   C1752727:Proteasome [Molecular Function]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.168: Under these conditions, we observed a strong inhibition of the resveratrol-induced A decrease (Fig. 5C, panel b). 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a strong inhibition of the resveratrol-induced A decrease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "(Fig. 5C,"

Phrase: "panel b"

Phrase: ")."
Processing 00000000.tx.169: View larger version (33K): [in this window] [in a new window]  FIGURE 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 6."
Processing 00000000.tx.170: Effect of resveratrol analogues on A levels. 

Phrase: "Effect of resveratrol analogues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on A levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.171: APP695-HEK293 cells were treated for 24 h with the indicated concentrations of resveratrol analogues (dissolved in Me2SO). 

Phrase: "APP695-HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2936239:HEK293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated for 24 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "with the indicated concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of resveratrol analogues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243071:Analogue [Chemical Viewed Structurally]

Phrase: "("

Phrase: "dissolved in Me2SO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1549535:Dissolve [Functional Concept]

Phrase: ")."
Processing 00000000.tx.172: Total sA was analyzed as in Fig. 

Phrase: "Total sA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.173: 2B. 

Phrase: "2B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450354:2b [Intellectual Product]
  1000   C1706096:2B [Research Activity]
Processing 00000000.tx.174: The final concentration of Me2SO was adjusted to 0.04% (v/v) in all conditions. 

Phrase: "The final concentration of Me2SO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "adjusted to 0.04%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0456081:Adjusted [Functional Concept]

Phrase: "(v/v) in all conditions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0560268:%V/V [Quantitative Concept]
   806   C2349105:V(V) [Element, Ion, or Isotope]
Processing 00000000.tx.175: The histogram shows the relative amounts of total sA detected by WB in the upper panel.  

Phrase: "The histogram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348974:Histogram [Manufactured Object]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the relative amounts of total sA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:amounts [Quantitative Concept]

Phrase: "detected by WB"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "in the upper panel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.176: We then investigated whether resveratrol directly stimulates proteasome activity. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "resveratrol directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "proteasome activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1622946:proteasome activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.177: In Fig. 

Phrase: "In Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.178: 5D, the chymotrypsin-like activity of purified proteasome was monitored upon in vitro incubation with resveratrol. 

Phrase: "5D,"

Phrase: "the chymotrypsin-like activity of purified proteasome"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1150252:chymotrypsin activity [Molecular Function]
   774   C1622946:proteasome activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "monitored upon in vitro incubation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
   726   C0030695:monitor [Health Care Activity]
   726   C0150369:monitor [Health Care Activity]
   726   C0181904:Monitor [Medical Device]
   726   C0596972:Monitor [Medical Device]
   726   C1521743:Monitor [Professional or Occupational Group]
   726   C1704646:Monitor [Manufactured Object]

Phrase: "with resveratrol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.179: The same activity was also assessed from endogenous proteasome in cell extracts after treatment with the polyphenol in cell cultures (Fig. 5C). 

Phrase: "The same activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "also"

Phrase: "assessed from endogenous proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205227:Endogenous [Functional Concept]
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1516048:Assessed [Activity]
   770   C1752727:Proteasome [Molecular Function]

Phrase: "in cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007634:Cell [Cell]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "extracts after treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C0001758:After-Treatment [Health Care Activity]
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C2828366:Extract [Substance]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with the polyphenol in cell cultures"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007585:Cell Cultures [Laboratory Procedure]
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.180: No significant effect of resveratrol on the chymotrypsin-like activity of purified or endogenous proteasome was observed (histograms in Fig. 5, D and C, respectively). 

Phrase: "No significant effect of resveratrol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the chymotrypsin-like activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1150252:chymotrypsin activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C1413809:chymotrypsin-like [Gene or Genome]

Phrase: "of purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "or"

Phrase: "endogenous proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(histograms in Fig. 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2348974:Histogram [Manufactured Object]

Phrase: "D and C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012358:D and C [Therapeutic or Preventive Procedure]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.181: Because resveratrol effectively reduced A levels after 24 h of incubation, we also asked whether resveratrol modifies proteasome subunit transcription. 

Phrase: "Because"

Phrase: "resveratrol effectively reduced A levels after 24 h of incubation,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "we also"

Phrase: "asked"

Phrase: "whether"

Phrase: "resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "modifies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "proteasome subunit transcription."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040649:Transcription [Genetic Function]
Processing 00000000.tx.182: We found that resveratrol treatment does not markedly affect the steady-state levels of several proteasome subunits in HEK293 cells (Fig. 5C, panel a, and Fig. 5E, panel a). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that resveratrol treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "does"

Phrase: "not markedly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0522501:Markedly [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the steady-state levels of several proteasome subunits"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0678587:steady state [Natural Phenomenon or Process]
   754   C0683927:state level [Spatial Concept]
   744   C0205361:Steady [Qualitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C1301808:State [Geographic Area]
   744   C1442792:State [Functional Concept]
   744   C3148680:State [Geographic Area]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "in HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5C,"

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a,"

Phrase: "and"

Phrase: "Fig. 5E,"

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "a"

Phrase: ")."
Processing 00000000.tx.183: Together these results demonstrate that resveratrol promotes a proteasome-dependent intracellular degradation of A via a mechanism that does not increase total proteasome activity. 

Phrase: "Together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "a proteasome-dependent intracellular degradation of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "via a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "total proteasome activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1622946:proteasome activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.184: Consistent with this conclusion, levels of -catenin, a cytosolic protein degraded by the ubiquitin proteasome system (25), are not affected by resveratrol in HEK293 cells (Fig. 5E, panel b). 

Phrase: "Consistent with this conclusion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "levels of -catenin,"

Phrase: "a cytosolic protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "degraded by the ubiquitin proteasome system"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0449913:System [Functional Concept]
   753   C1325620:proteasome [Cell Component]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   753   C1752727:Proteasome [Molecular Function]
   753   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by resveratrol"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]

Phrase: "in HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5E,"

Phrase: "panel b"

Phrase: ")."
Processing 00000000.tx.185: We then investigated the anti-amyloidogenic effect of several resveratrol analogues. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the anti-amyloidogenic effect of several resveratrol analogues."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.186: Three analogues were tested: piceatannol (trans-3,3',4,5'-tetrahydroxystilbene), which contains an additional hydroxyl group at C-3, and two methoxy analogues, trimethoxy-resveratrol (trans-3,4',5-trimethoxystilbene) and TMS. 

Phrase: "Three analogues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243071:Analogue [Chemical Viewed Structurally]

Phrase: "were"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ":"

Phrase: "piceatannol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1176007:piceatannol [Organic Chemical,Pharmacologic Substance]

Phrase: "(trans-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2826298:TRANS [Idea or Concept]

Phrase: "3',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5'-tetrahydroxystilbene"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an additional hydroxyl group at C-3,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   778   C0700307:hydroxyl group [Inorganic Chemical]
           Hydroxyl
   774   C0441837:Group C [Classification]
   774   C0441869:Group 3 [Intellectual Product]
   748   C0063146:Hydroxyl [Inorganic Chemical]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "two methoxy analogues,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0243071:Analogue [Chemical Viewed Structurally]

Phrase: "trimethoxy-resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "(trans-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2826298:TRANS [Idea or Concept]

Phrase: "4',"

Phrase: "5-trimethoxystilbene"

Phrase: ")"

Phrase: "and"

Phrase: "TMS."
Processing 00000000.tx.187: Interestingly, the three analogues were able to decrease A levels (Fig. 6). 

Phrase: "Interestingly,"

Phrase: "the three analogues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243071:Analogue [Chemical Viewed Structurally]

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.188: However, compared with resveratrol (Fig. 2A), piceatannol and trimethoxy-resveratrol were less potent, whereas TMS had a very comparable potency in reducing the amounts of A (Fig. 6).  

Phrase: "However,"

Phrase: "compared with resveratrol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]
   790   C1707455:Compared [Activity]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: ","

Phrase: "piceatannol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1176007:piceatannol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "trimethoxy-resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "less potent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   761   C3245505:Potential [Qualitative Concept]

Phrase: "whereas"

Phrase: "TMS"

Phrase: "had"

Phrase: "a very comparable potency in reducing"

Phrase: "the amounts of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.189: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Our data show that resveratrol strongly reduces A produced by different cell lines expressing wild type or Swedish mutant APP695. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that resveratrol strongly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "reduces"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "produced by different cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0007600:Cell lines [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:lines [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1705242:Different [Qualitative Concept]
   760   C1948049:Cell [Spatial Concept]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "Swedish mutant APP695."
Processing 00000000.tx.190: Resveratrol acts by promoting the intracellular degradation of the amyloid peptide by a mechanism that implicates the proteasome. 

Phrase: "Resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "acts by promoting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033414:Promoting [Activity]
   790   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "the intracellular degradation of the amyloid peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1523817:peptide degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "by a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "implicates"

Phrase: "the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.191: Pharmacological studies show that none of the previously reported A-degrading metalloendopeptidases, NEP, ECE-1 and -2, or IDE, are involved in this clearance. 

Phrase: "Pharmacological studies"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1831759:pharmacological studies [Diagnostic Procedure]
   861   C0031330:Pharmacological [Biomedical Occupation or Discipline]
   861   C0205464:pharmacological [Functional Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   789 E C1524059:pharmacology [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "none of the previously reported A-"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0456148:None [Quantitative Concept]
   753   C0549184:None [Quantitative Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C3496591:Reported [Clinical Attribute]
   719 E C3273238:Report [Intellectual Product]

Phrase: "degrading metalloendopeptidases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442934:Metalloendopeptidases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "ECE-1 and -2,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "or"

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "are"

Phrase: "involved in this clearance."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1314939:Involved [Functional Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.192: Finally, we demonstrate the anti-amyloidogenic activity of two methoxy analogues of resveratrol, trimethoxy-resveratrol and TMS, suggesting that chemical modifications of resveratrol can be done in the context of improving its potency, stability, and bioavailability and therefore its therapeutic use. 

Phrase: "Finally,"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "the anti-amyloidogenic activity of two methoxy analogues of resveratrol,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1561536:*Activity [Idea or Concept]

Phrase: "trimethoxy-resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "TMS,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that chemical modifications of resveratrol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0392747:Modification [Functional Concept]
   726   C1554963:modification [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "done in the context of improving"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0449255:Context [Finding]
   753   C0542559:Context [Functional Concept]
   753   C1272695:Done [Qualitative Concept]
   753   C1272745:Improving [Qualitative Concept]
   753   C2746065:Done [Temporal Concept]

Phrase: "its potency,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   884   C3245505:Potential [Qualitative Concept]

Phrase: "stability,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "bioavailability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005508:Bioavailability [Quantitative Concept]
  1000   C1706947:BIO-AVAILABILITY [Research Activity]
   928 E C0935763:Bioavailable [Qualitative Concept]

Phrase: "and"

Phrase: "therefore"

Phrase: "its therapeutic use."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039795:therapeutic use [Therapeutic or Preventive Procedure]
   861   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   861   C0042153:use [Functional Concept]
   861   C0302350:Therapeutic [Functional Concept]
   861   C0457083:Use [Functional Concept]
   861   C1947944:Use [Intellectual Product]
Processing 00000000.tx.193: Additional studies will be needed to fully elucidate the role of the proteasome in this mechanism of intracellular clearance of A. 

Phrase: "Additional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "will"

Phrase: "be"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to fully"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "the role of the proteasome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in this mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "of intracellular clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "of A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.194: A number of possible functions of the proteasome in the regulation of A metabolism have been ascribed to the multicatalytic complex (22). 

Phrase: "A number of possible functions of the proteasome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of A metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "ascribed to the multicatalytic complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.195: The proteasome targets for degradation C99 and three core components of the -secretase complex, presenilins, APH-1, and Pen-2 (22), suggesting that proteasome activation may decrease A levels by reducing the amounts of C99 available and by altering -secretase activity. 

Phrase: "The proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "targets for degradation C99"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
   770   C1521840:Target [Functional Concept]
   770   C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "three core components of the -secretase complex,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0449432:Components [Manufactured Object]
   714 E C1705248:Component [Conceptual Entity]

Phrase: "presenilins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "APH-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1332101:APH [Gene or Genome]
   861   C1705550:APH [Gene or Genome]

Phrase: "and"

Phrase: "Pen-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3541303:PEN-2 [Gene or Genome]
   861   C3273588:Pen [Manufactured Object]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that proteasome activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "may"

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "A levels by reducing"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "the amounts of C99"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "available"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]

Phrase: "and by altering -secretase activity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1515981:And [Idea or Concept]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.196: Our data show no reduction of C99 levels (Fig. 3A, panel c) or alteration of the -secretase-mediated cleavages of APP or N-cadherin upon resveratrol treatment (Figs. 3 and 4), thus excluding the possibility that resveratrol lowers A by promoting the proteasomal degradation of C99 or any -secretase components. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "no reduction of C99 levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 3A,"

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "c)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "alteration of the -secretase-mediated cleavages of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1515926:Alteration [Idea or Concept]

Phrase: "or"

Phrase: "N-cadherin upon resveratrol treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1413277:N-CADHERIN [Gene or Genome]
   760   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441922:N+ [Intellectual Product]
   760   C1413274:cadherin [Gene or Genome]
   760   C1553036:[n] [Quantitative Concept]

Phrase: "(Figs. 3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: ","

Phrase: "thus"

Phrase: "excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "lowers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "the proteasomal degradation of C99"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "or"

Phrase: "any -secretase components."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.197: Recent evidence also suggests that A can be degraded by a proteasome-dependent endoplasmic reticulum (ER)-associated degradation (26). 

Phrase: "Recent evidence also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "be"

Phrase: "degraded by a proteasome-dependent endoplasmic reticulum (ER)-associated degradation"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   818   C3178997:Endoplasmic Reticulum-Associated Degradation [Molecular Function]
   764   C0014239:Endoplasmic Reticulum [Cell Component]
   742   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   742   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0243125:degradation [Functional Concept]
   742   C0332281:Associated [Qualitative Concept]
   742   C0699900:Degradation [Organism Function]
   742   C0851827:Dependent [Qualitative Concept]
   742   C1325620:proteasome [Cell Component]
   742   C1701901:Dependent [Qualitative Concept]
   742   C1752727:Proteasome [Molecular Function]
   742   C1881707:DEGRADED [Phenomenon or Process]
   742   C3244310:dependent [Functional Concept]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.198: Using cell-free reconstitutions of ER-derived brain microsomes, Schmitz et al. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cell-free reconstitutions of ER-derived brain microsomes,"

Phrase: "Schmitz et al."
Processing 00000000.tx.199: (26) show that A can translocate from the ER to the cytosol where it is directly degraded by the proteasome. 

Phrase: "(26"

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "translocate from the ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]

Phrase: "to the cytosol where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1383501:Cytosol [Cell Component]

Phrase: "it"

Phrase: "is"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "degraded by the proteasome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   770   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.200: It is conceivable that resveratrol promotes such a clearance mechanism. 

Phrase: "It"

Phrase: "is"

Phrase: "conceivable"

Phrase: "that resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "such a clearance mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.201: However, because ER A represents a small fraction of total A produced and because a small pool of A produced in the ER appears to be controlled by ER-associated degradation, it is unlikely that the severe reduction of A levels observed in the presence of resveratrol is entirely due to an increase of this clearance mechanism. 

Phrase: "However,"

Phrase: "because"

Phrase: "ER A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0014239:Endoplasmic Reticulum [Cell Component]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a small fraction of total A produced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0439160:Fraction of total [Quantitative Concept]
   778   C1264633:Fraction of [Quantitative Concept]
           Fraction
   748   C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "because"

Phrase: "a small pool of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0337051:Pool [Geographic Area]
   760   C1509144:pool [Clinical Attribute]
   760   C2349200:Pool [Functional Concept]

Phrase: "produced in the ER"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "controlled by ER-associated degradation,"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   882   C3178997:Endoplasmic Reticulum-Associated Degradation [Molecular Function]
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   790   C0332298:Controlled by [Functional Concept]
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   753   C0243125:degradation [Functional Concept]
   753   C0332281:Associated [Qualitative Concept]
   753   C0699900:Degradation [Organism Function]
   753   C2587213:Controlled [Functional Concept]
   719 E C0243148:control [Qualitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1550141:Control [Substance]
   719 E C1706221:Associate [Professional or Occupational Group]
   719 E C1882979:Control [Conceptual Entity]
   719 E C3274648:Control [Qualitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "the severe reduction of A levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "observed in the presence of resveratrol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1441672:Observed [Functional Concept]

Phrase: "is"

Phrase: "entirely due to an increase of this clearance mechanism."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0678226:Due to [Functional Concept]
           due
   742   C0441712:Mechanism [Functional Concept]
   742   C0442805:Increase [Functional Concept]
   742   C0449297:Clearance [Qualitative Concept]
   742   C1382187:Clearance [Clinical Attribute]
   742   C1706376:Mechanism [Manufactured Object]
   742   C2825073:Clearance [Natural Phenomenon or Process]
   742   C3146286:Due [Idea or Concept]
Processing 00000000.tx.202: We therefore hypothesize that resveratrol may act indirectly by selectively stimulating the proteasomal degradation of yet to be identified critical regulators of A clearance. 

Phrase: "We therefore"

Phrase: "hypothesize"

Phrase: "that resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "may"

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "indirectly by selectively"

Phrase: "stimulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulating [Natural Phenomenon or Process]

Phrase: "the proteasomal degradation of yet to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "be"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "critical regulators of A clearance."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0182953:regulators [Medical Device]
   726 E C1704734:Regulator [Medical Device]
   726 E C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.203: It will be also important to determine what the molecular targets of resveratrol are in the pathway of A clearance. 

Phrase: "It"

Phrase: "will"

Phrase: "be"

Phrase: "also important to"

Phrase: "determine"

Phrase: "what the molecular targets of resveratrol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]
   719   C1521840:Target [Functional Concept]
   719   C2986546:TARGET [Diagnostic Procedure]

Phrase: "are in the pathway of A clearance."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0449297:Clearance [Qualitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1382187:Clearance [Clinical Attribute]
   748   C1551058:Are [Quantitative Concept]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]
   748   C2825073:Clearance [Natural Phenomenon or Process]
Processing 00000000.tx.204: Resveratrol interacts with several proteins, including members of the sirtuin family. 

Phrase: "Resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "interacts with several proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "members of the sirtuin family."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C0086282:Family Members [Family Group]
   781 E C1611821:Family Member [Intellectual Product]
   760   C0680022:members [Population Group]
   726 E C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.205: Sirtuins are evolutionarily conserved deacetylases with important functions in longevity (27). 

Phrase: "Sirtuins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1136177:Sirtuins [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "evolutionarily conserved deacetylases with important functions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1333261:Deacetylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in longevity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023980:Longevity [Temporal Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.206: Resveratrol was found to act as a potent activator of the human sirtuin SIRT1 in vitro and of the yeast homologue Sir2 in vivo, a mechanism that may extend life span in yeast (28). 

Phrase: "Resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act as a potent activator of the human sirtuin SIRT1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0079613:ACT [Therapeutic or Preventive Procedure]
   739   C0086418:Human [Human]
   739   C1423062:SIRT1 [Gene or Genome]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and of the yeast homologue Sir2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0036025:yeast [Fungus]
   753   C0043392:Yeast [Food]
   753   C0043393:Yeast [Fungus]
   753   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   753   C1149630:SIR2 [Genetic Function]
   753   C1334043:Homologue [Gene or Genome]
   753   C1515981:And [Idea or Concept]
   753   C3539783:SIR2 [Gene or Genome]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "may"

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "life span in yeast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0870809:life span [Group Attribute]
   770   C0376558:Life [Idea or Concept]
   770   C1711300:Span [Conceptual Entity]
   770   C2700613:Span [Quantitative Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.207: Moreover, resveratrol and SIRT1 activation have recently been linked to neuroprotective pathways in models of axonal degeneration (29) and of neuronal dysfunctions caused by mutant polyglutamines (30). 

Phrase: "Moreover,"

Phrase: "resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "SIRT1 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "linked to neuroprotective pathways"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1704259:Pathways [Molecular Function]
   770   C1705987:Pathways [Conceptual Entity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "in models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "of axonal degeneration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1837496:Axonal degeneration [Finding]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]
   789   C0004461:Axon [Cell Component]

Phrase: "(29"

Phrase: ")"

Phrase: "and of neuronal dysfunctions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1515981:And [Idea or Concept]
   737   C0031847:dysfunction [Functional Concept]
   737   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "caused by mutant polyglutamines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0596988:Mutant [Cell or Molecular Dysfunction]
   737   C0015127:cause [Functional Concept]
   737   C0384782:polyglutamine [Amino Acid, Peptide, or Protein]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.208: It would therefore be of interest to determine whether SIRT1 is involved in the resveratrol-induced decrease of A. 

Phrase: "It"

Phrase: "would"

Phrase: "therefore"

Phrase: "be of interest to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543488:Interest [Mental Process]
   770   C2987476:Be [Conceptual Entity]

Phrase: "determine"

Phrase: "whether"

Phrase: "SIRT1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1423062:SIRT1 [Gene or Genome]

Phrase: "is"

Phrase: "involved in the resveratrol-induced decrease of A."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]
   744   C0205263:Induced [Functional Concept]
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1314939:Involved [Functional Concept]
Processing 00000000.tx.209: Evidence is compelling that a decrease in proteasome activity occurs in AD brains (31, 32). 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "compelling"

Phrase: "that"

Phrase: "a decrease in proteasome activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "occurs in AD brains"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0006104:Brains [Body Part, Organ, or Organ Component]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   737 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.210: It is unclear, however, whether this decrease in proteasome activity is in parallel with an increase in A levels. 

Phrase: "It"

Phrase: "is"

Phrase: "unclear, however,"

Phrase: "whether"

Phrase: "this decrease in proteasome activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "is"

Phrase: "in parallel with an increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0150312:In [Quantitative Concept]
   760   C0332285:In [Spatial Concept]
   760   C2348042:Parallel [Qualitative Concept]
   760   C2826345:PARALLEL [Research Activity]

Phrase: "in A levels."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.211: It has been proposed that A itself may lead to proteasome inhibition (33), suggesting that high levels of A in AD brain may create a vicious cycle by inhibiting the proteasome and blocking the degradation of critical regulators of its own clearance. 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "itself"

Phrase: "may"

Phrase: "lead to proteasome inhibition"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C1752727:Proteasome [Molecular Function]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   770   C3463820:Inhibition [Activity]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that high levels of A"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in AD brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "may"

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "a vicious cycle by inhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511572:Cycle [Temporal Concept]

Phrase: "the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the degradation of critical regulators of its own clearance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0243125:degradation [Functional Concept]
   742   C0699900:Degradation [Organism Function]
Processing 00000000.tx.212: In this context, our data reveal an important mechanism of selective proteasome activation in the anti-amyloidogenic effect of resveratrol and support the therapeutic potential of this natural polyphenol.  

Phrase: "In this context,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "an important mechanism of selective proteasome activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "in the anti-amyloidogenic effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "of resveratrol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073096:resveratrol [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the therapeutic potential of this natural polyphenol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.213: FOOTNOTES  * This work was supported by National Institute of Mental Health Grant 38623 and by a grant from the American Health Assistance Foundation. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Institute of Mental Health Grant 38623"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   849   C0027466:National Institute of Mental Health [Health Care Related Organization]
           mental health national institute
   784   C0027468:health national institute [Health Care Related Organization]
   764   C0025353:mental health [Mental Process]
   764   C1555896:Mental Health [Intellectual Product]
   742   C0018173:Grant [Quantitative Concept]
   742   C0018684:Health [Idea or Concept]
   742   C0021622:institute [Organization]
   742   C0229992:mental [Mental Process]
   742   C1272753:Institute [Idea or Concept]
   742   C1521721:Supported [Conceptual Entity]
   742   C1548284:Grant [Idea or Concept]
   742   C3245503:national [Intellectual Product]
   708 E C0183683:Support [Medical Device]

Phrase: "and by a grant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018173:Grant [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C1548284:Grant [Idea or Concept]

Phrase: "from the American Health Assistance Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.214: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.215: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.216: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.217: 1 To whom correspondence should be addressed: The Litwin-Zucker Research Center for the Study of Alzheimer's Disease and Memory Disorders, North Shore-Long Island Jewish Institute for Medical Research, 350 Community Dr., Manhasset, NY 11030. 

Phrase: "1 To whom correspondence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0282413:Correspondence [Intellectual Product]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "The Litwin-Zucker Research Center for the Study of Alzheimer's Disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0683939:research center [Manufactured Object,Organization]
   738   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Memory Disorders,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025261:Memory Disorders [Mental or Behavioral Dysfunction]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "North Shore-Long Island Jewish Institute for Medical Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0035172:Research Institute [Organization]
   742   C0021622:institute [Organization]
   742   C1272753:Institute [Idea or Concept]

Phrase: "350 Community Dr., Manhasset,"

Phrase: "NY 11030."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]
Processing 00000000.tx.218: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.219: 516-562-3492; 

Phrase: "516-562-3492"

Phrase: ";"
Processing 00000000.tx.220: E-mail: pmaramba{at}aecom.yu.edu . 2 The abbreviations used are: AD, Alzheimer's disease; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "pmaramba{at}aecom.yu.edu . 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
   799   C1006780:yu [Plant]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.221: Suc, succinyl; 

Phrase: "Suc,"

Phrase: "succinyl"

Phrase: ";"
Processing 00000000.tx.222: TMS, trans-2,3',4,5'-tetramethoxystilbene; 

Phrase: "TMS,"

Phrase: "trans-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2826298:TRANS [Idea or Concept]

Phrase: "3',"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5'-tetramethoxystilbene"

Phrase: ";"
Processing 00000000.tx.223: ALLN, N-acetyl-LL-norleucinal-CHO; 

Phrase: "ALLN,"

Phrase: "N-acetyl-LL-norleucinal-CHO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441922:N+ [Intellectual Product]
   804   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.224: ELISA, enzyme-linked immunosorbent assay; 

Phrase: "ELISA,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "enzyme-linked immunosorbent assay"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0014441:Enzyme-Linked Immunosorbent Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021075:immunosorbent [Indicator, Reagent, or Diagnostic Aid]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.225: ECE, endothelin-converting enzyme; 

Phrase: "ECE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414244:ECE [Gene or Genome]

Phrase: "endothelin-converting enzyme"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C2745878:endothelin-converting enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0079284:Endothelin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   743 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.226: IDE, insulin-degrading enzyme; 

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.227: A, amyloid-; 

Phrase: "A,"

Phrase: "amyloid-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.228: APP, amyloid- precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid- precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.229: AMC, amido-4-methylcoumarin; 

Phrase: "AMC,"

Phrase: "amido-4-methylcoumarin"

Phrase: ";"
Processing 00000000.tx.230: Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; 

Phrase: "Tricine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0077068:tricine [Organic Chemical]

Phrase: "N-[2-hydroxy-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441922:N+ [Intellectual Product]
   812   C0700307:Hydroxy [Inorganic Chemical]
   812   C1553036:[n] [Quantitative Concept]

Phrase: "1-bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0556985:BIS [Temporal Concept]
   861   C2247301:BIS [Molecular Function]
   861   C3540495:BIS [Intellectual Product]

Phrase: "hydroxymethyl"

Phrase: ")"

Phrase: "ethyl"

Phrase: "]glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: ";"
Processing 00000000.tx.231: WB, Western blotting; 

Phrase: "WB,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.232: IP, immunoprecipitation; 

Phrase: "IP,"

Phrase: "immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.233: NEP, neprilysin; 

Phrase: "NEP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "neprilysin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.234: MOPS, 4-morpholinepropanesulfonic acid; 

Phrase: "MOPS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0066823:MOPS [Organic Chemical]
  1000   C1271466:Mops [Mammal]

Phrase: "4-morpholinepropanesulfonic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.235: ER, endoplasmic reticulum; 

Phrase: "ER,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: ";"
Processing 00000000.tx.236: siRNA, small interfering RNA; 

Phrase: "siRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1099354:siRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "small interfering RNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1099354:RNA, Small Interfering [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0521102:interfering [Qualitative Concept]
   827   C0700321:Small [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.237: TBS, Tris-buffered saline; 

Phrase: "TBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
  1000   C1532188:Tbsp [Quantitative Concept]

Phrase: "Tris-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.238: sA, secreted amyloid-; 

Phrase: "sA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036243:SA [Geographic Area]
  1000   C1539696:SA [Gene or Genome]
  1000   C1825840:SA [Gene or Genome]
  1000   C3539736:Sa [Spatial Concept]

Phrase: "secreted amyloid-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.239: Z, benzyloxycarbonyl.  

Phrase: "Z,"

Phrase: "benzyloxycarbonyl."
Processing 00000000.tx.240: ACKNOWLEDGMENTS  We thank Drs. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs."
Processing 00000000.tx.241: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.242: Checler, N. 

Phrase: "Checler,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.243: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.244: Robakis, L. 

Phrase: "Robakis,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.245: D'Adamio, and P. 

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.246: D. 

Phrase: "D."
Processing 00000000.tx.247: Mehta for generously providing us with antibodies, cDNAs, and cell lines.  

Phrase: "Mehta for generously"

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "us with antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "cDNAs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "cell lines."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.248: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Hardy, J., and Selkoe, D. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.249: J. 

Phrase: "J."
Processing 00000000.tx.250: (2002) Science 297, 353356[Abstract/Free FullText] Tanzi, R. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Science 297,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "353356"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.251: E., and Bertram, L. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Bertram,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.252: (2005) Cell 120, 545555[CrossRef][Medline] [OrderarticleviaInfotrieve] Passer, B., Pellegrini, L., Russo, C., Siegel, R. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Cell 120,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "545555"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Passer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0491928:PASSER [Medical Device]
  1000   C0999347:Passer [Bird]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Pellegrini,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Russo,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Siegel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.253: M., Lenardo, M. 

Phrase: "M."

Phrase: ","

Phrase: "Lenardo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.254: J., Schettini, G., Bachmann, M., Tabaton, M., and D'Adamio, L. 

Phrase: "J.,"

Phrase: "Schettini,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bachmann,"

Phrase: "M."

Phrase: ","

Phrase: "Tabaton,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.255: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.256: Alzheimers Dis. 

Phrase: "Alzheimers Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0451119:DIS [Intellectual Product]
   861   C1444662:DIS [Finding]
Processing 00000000.tx.257: 2, 289301[Medline] [OrderarticleviaInfotrieve] Checler, F. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "289301"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.258: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.259: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.260: 65, 14311444[Medline] [OrderarticleviaInfotrieve] Annaert, W., and De Strooper, B. 

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "14311444"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Annaert,"

Phrase: "W.,"

Phrase: "and"

Phrase: "De Strooper,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.261: (2002) Annu. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.262: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.263: Cell Dev. 

Phrase: "Cell Dev."
Processing 00000000.tx.264: Biol. 

Phrase: "Biol."
Processing 00000000.tx.265: 18, 2551[CrossRef][Medline] [OrderarticleviaInfotrieve] Marambaud, P., and Robakis, N. 

Phrase: "18,"

Phrase: "2551"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Marambaud,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Robakis,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.266: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.267: (2005) Genes Brain Behav. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Genes Brain Behav."
Processing 00000000.tx.268: 4, 134146[CrossRef][Medline] [OrderarticleviaInfotrieve] Luchsinger, J. 

Phrase: "4,"

Phrase: "134146"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Luchsinger,"

Phrase: "J."
Processing 00000000.tx.269: A., Tang, M. 

Phrase: "A.,"

Phrase: "Tang,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.270: X., Siddiqui, M., Shea, S., and Mayeux, R. 

Phrase: "X.,"

Phrase: "Siddiqui,"

Phrase: "M."

Phrase: ","

Phrase: "Shea,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Mayeux,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.271: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.272: Am. 

Phrase: "Am."
Processing 00000000.tx.273: Geriatr. 

Phrase: "Geriatr."
Processing 00000000.tx.274: Soc. 

Phrase: "Soc."
Processing 00000000.tx.275: 52, 540546[CrossRef][Medline] [OrderarticleviaInfotrieve] Lindsay, J., Laurin, D., Verreault, R., Hebert, R., Helliwell, B., Hill, G. 

Phrase: "52,"

Phrase: "540546"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lindsay,"

Phrase: "J.,"

Phrase: "Laurin,"

Phrase: "D."

Phrase: ","

Phrase: "Verreault,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hebert,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Helliwell,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442532:Hill [Spatial Concept]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.276: B., and McDowell, I. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "McDowell,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.277: (2002) Am. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.278: J. 

Phrase: "J."
Processing 00000000.tx.279: Epidemiol. 

Phrase: "Epidemiol."
Processing 00000000.tx.280: 156, 445453[Abstract/Free FullText] Orgogozo, J. 

Phrase: "156,"

Phrase: "445453"

Phrase: "[Abstract/Free FullText"

Phrase: "] Orgogozo,"

Phrase: "J."
Processing 00000000.tx.281: M., Dartigues, J. 

Phrase: "M."

Phrase: ","

Phrase: "Dartigues,"

Phrase: "J."
Processing 00000000.tx.282: F., Lafont, S., Letenneur, L., Commenges, D., Salamon, R., Renaud, S., and Breteler, M. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lafont,"

Phrase: "S."

Phrase: ","

Phrase: "Letenneur,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Commenges,"

Phrase: "D."

Phrase: ","

Phrase: "Salamon,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Renaud,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Breteler,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.283: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.284: (1997) Rev. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.285: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.286: (Paris) 153, 185192[Medline] [OrderarticleviaInfotrieve] Truelsen, T., Thudium, D., and Gronbaek, M. 

Phrase: "(Paris"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: ")"

Phrase: "153,"

Phrase: "185192"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Truelsen,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Thudium,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Gronbaek,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.287: (2002) Neurology 59, 13131319[Abstract/Free FullText] Savaskan, E., Olivieri, G., Meier, F., Seifritz, E., Wirz-Justice, A., and Muller-Spahn, F. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neurology 59,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "13131319"

Phrase: "[Abstract/Free FullText"

Phrase: "] Savaskan,"

Phrase: "E.,"

Phrase: "Olivieri,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Meier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Seifritz,"

Phrase: "E.,"

Phrase: "Wirz-Justice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022437:Justice [Qualitative Concept]

Phrase: "A.,"

Phrase: "and"

Phrase: "Muller-Spahn,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.288: (2003) Gerontology 49, 380383[CrossRef][Medline] [OrderarticleviaInfotrieve] Jang, J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Gerontology 49,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017469:Gerontology [Biomedical Occupation or Discipline]
   861   C0205767:Gerontology [Occupation or Discipline]

Phrase: "380383"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Jang,"

Phrase: "J."
Processing 00000000.tx.289: H., and Surh, Y. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Surh,"

Phrase: "Y."
Processing 00000000.tx.290: J. 

Phrase: "J."
Processing 00000000.tx.291: (2003) Free Radic. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.292: Biol. 

Phrase: "Biol."
Processing 00000000.tx.293: Med. 

Phrase: "Med."
Processing 00000000.tx.294: 34, 11001110[CrossRef][Medline] [OrderarticleviaInfotrieve] Han, Y. 

Phrase: "34,"

Phrase: "11001110"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Han,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Han [Language]

Phrase: "Y."
Processing 00000000.tx.295: S., Zheng, W. 

Phrase: "S."

Phrase: ","

Phrase: "Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "W."
Processing 00000000.tx.296: H., Bastianetto, S., Chabot, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bastianetto,"

Phrase: "S."

Phrase: ","

Phrase: "Chabot,"

Phrase: "J."
Processing 00000000.tx.297: G., and Quirion, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Quirion,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.298: (2004) Br. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Br."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]
Processing 00000000.tx.299: J. 

Phrase: "J."
Processing 00000000.tx.300: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.301: 141, 9971005[CrossRef][Medline] [OrderarticleviaInfotrieve] Barelli, H., Lebeau, A., Vizzavona, J., Delaere, P., Chevallier, N., Drouot, C., Marambaud, P., Ancolio, K., Buxbaum, J. 

Phrase: "141,"

Phrase: "9971005"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Barelli,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lebeau,"

Phrase: "A.,"

Phrase: "Vizzavona,"

Phrase: "J.,"

Phrase: "Delaere,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Chevallier,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Drouot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Marambaud,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ancolio,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Buxbaum,"

Phrase: "J."
Processing 00000000.tx.302: D., Khorkova, O., Heroux, J., Sahasrabudhe, S., Martinez, J., Warter, J. 

Phrase: "D."

Phrase: ","

Phrase: "Khorkova,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Heroux,"

Phrase: "J.,"

Phrase: "Sahasrabudhe,"

Phrase: "S."

Phrase: ","

Phrase: "Martinez,"

Phrase: "J.,"

Phrase: "Warter,"

Phrase: "J."
Processing 00000000.tx.303: M., Mohr, M., and Checler, F. 

Phrase: "M."

Phrase: ","

Phrase: "Mohr,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Checler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.304: (1997) Mol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.305: Med. 

Phrase: "Med."
Processing 00000000.tx.306: 3, 695707[Medline] [OrderarticleviaInfotrieve] Marambaud, P., Wen, P. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "695707"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Marambaud,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014511:Wen [Anatomical Abnormality]
  1000   C0086809:Wen [Anatomical Abnormality]
  1000   C1547963:Wen [Intellectual Product]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.307: H., Dutt, A., Shioi, J., Takashima, A., Siman, R., and Robakis, N. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dutt,"

Phrase: "A.,"

Phrase: "Shioi,"

Phrase: "J.,"

Phrase: "Takashima,"

Phrase: "A.,"

Phrase: "Siman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Robakis,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.308: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.309: (2003) Cell 114, 635645[CrossRef][Medline] [OrderarticleviaInfotrieve] Marambaud, P., Shioi, J., Serban, G., Georgakopoulos, A., Sarner, S., Nagy, V., Baki, L., Wen, P., Efthimiopoulos, S., Shao, Z., Wisniewski, T., and Robakis, N. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Cell 114,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "635645"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Marambaud,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Shioi,"

Phrase: "J.,"

Phrase: "Serban,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Georgakopoulos,"

Phrase: "A.,"

Phrase: "Sarner,"

Phrase: "S."

Phrase: ","

Phrase: "Nagy,"

Phrase: "V.,"

Phrase: "Baki,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Wen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014511:Wen [Anatomical Abnormality]
  1000   C0086809:Wen [Anatomical Abnormality]
  1000   C1547963:Wen [Intellectual Product]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Efthimiopoulos,"

Phrase: "S."

Phrase: ","

Phrase: "Shao,"

Phrase: "Z.,"

Phrase: "Wisniewski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Robakis,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.310: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.311: (2002) EMBO J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.312: 21, 19481956[Abstract/Free FullText] Turner, A. 

Phrase: "21,"

Phrase: "19481956"

Phrase: "[Abstract/Free FullText"

Phrase: "] Turner,"

Phrase: "A."
Processing 00000000.tx.313: J., Fisk, L., and Nalivaeva, N. 

Phrase: "J.,"

Phrase: "Fisk,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Nalivaeva,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.314: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.315: (2004) Ann. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.316: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.317: Y. 

Phrase: "Y."
Processing 00000000.tx.318: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.319: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.320: 1035, 120[Abstract/Free FullText] Melzig, M. 

Phrase: "1035,"

Phrase: "120"

Phrase: "[Abstract/Free FullText"

Phrase: "] Melzig,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.321: F., and Escher, F. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Escher,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.322: (2002) Pharmazie 57, 556558[Medline] [OrderarticleviaInfotrieve] Joe, A. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Pharmazie 57,"

Phrase: "556558"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Joe,"

Phrase: "A."
Processing 00000000.tx.323: K., Liu, H., Suzui, M., Vural, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Liu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Suzui,"

Phrase: "M."

Phrase: ","

Phrase: "Vural,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.324: E., Xiao, D., and Weinstein, I. 

Phrase: "E.,"

Phrase: "Xiao,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Weinstein,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.325: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.326: (2002) Clin. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.327: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.328: 8, 893903[Abstract/Free FullText] Pozo-Guisado, E., Lorenzo-Benayas, M. 

Phrase: "8,"

Phrase: "893903"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pozo-Guisado,"

Phrase: "E.,"

Phrase: "Lorenzo-Benayas,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.329: J., and Fernandez-Salguero, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Fernandez-Salguero,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.330: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.331: (2004) Int. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.332: J. 

Phrase: "J."
Processing 00000000.tx.333: Cancer 109, 167173[CrossRef][Medline] [OrderarticleviaInfotrieve] Cao, Z., Fang, J., Xia, C., Shi, X., and Jiang, B. 

Phrase: "Cancer 109,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "167173"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Cao,"

Phrase: "Z.,"

Phrase: "Fang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0227136:Fang [Body Part, Organ, or Organ Component]

Phrase: "J.,"

Phrase: "Xia,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Shi,"

Phrase: "X.,"

Phrase: "and"

Phrase: "Jiang,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.334: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.335: (2004) Clin. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.336: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.337: 10, 52535263[Abstract/Free FullText] de Vrij, F. 

Phrase: "10,"

Phrase: "52535263"

Phrase: "[Abstract/Free FullText"

Phrase: "] de Vrij,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.338: M., Fischer, D. 

Phrase: "M."

Phrase: ","

Phrase: "Fischer,"

Phrase: "D."
Processing 00000000.tx.339: F., van Leeuwen, F. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "van Leeuwen,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.340: W., and Hol, E. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Hol,"

Phrase: "E."
Processing 00000000.tx.341: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.342: (2004) Prog. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Prog."
Processing 00000000.tx.343: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.344: 74, 249270[CrossRef][Medline] [OrderarticleviaInfotrieve] Orlowski, M., and Wilk, S. 

Phrase: "74,"

Phrase: "249270"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Orlowski,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Wilk,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.345: (2000) Arch. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.346: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.347: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.348: 383, 116[CrossRef][Medline] [OrderarticleviaInfotrieve] Elofsson, M., Splittgerber, U., Myung, J., Mohan, R., and Crews, C. 

Phrase: "383,"

Phrase: "116"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Elofsson,"

Phrase: "M."

Phrase: ","

Phrase: "Splittgerber,"

Phrase: "U.,"

Phrase: "Myung,"

Phrase: "J.,"

Phrase: "Mohan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Crews,"

Phrase: "C."
Processing 00000000.tx.349: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.350: (1999) Chem. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.351: Biol. 

Phrase: "Biol."
Processing 00000000.tx.352: 6, 811822[CrossRef][Medline] [OrderarticleviaInfotrieve] Aberle, H., Bauer, A., Stappert, J., Kispert, A., and Kemler, R. 

Phrase: "6,"

Phrase: "811822"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Aberle,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bauer,"

Phrase: "A.,"

Phrase: "Stappert,"

Phrase: "J.,"

Phrase: "Kispert,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Kemler,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.353: (1997) EMBO J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.354: 16, 37973804[Abstract/Free FullText] Schmitz, A., Schneider, A., Kummer, M. 

Phrase: "16,"

Phrase: "37973804"

Phrase: "[Abstract/Free FullText"

Phrase: "] Schmitz,"

Phrase: "A.,"

Phrase: "Schneider,"

Phrase: "A.,"

Phrase: "Kummer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.355: P., and Herzog, V. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Herzog,"

Phrase: "V."
Processing 00000000.tx.356: (2004) Traffic 5, 89101[CrossRef][Medline] [OrderarticleviaInfotrieve] Guarente, L. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Traffic 5,"

Phrase: "89101"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Guarente,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.357: (2001) Trends Genet. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.358: 17, 391392[CrossRef][Medline] [OrderarticleviaInfotrieve] Howitz, K. 

Phrase: "17,"

Phrase: "391392"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Howitz,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.359: T., Bitterman, K. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Bitterman,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.360: J., Cohen, H. 

Phrase: "J.,"

Phrase: "Cohen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.361: Y., Lamming, D. 

Phrase: "Y.,"

Phrase: "Lamming,"

Phrase: "D."
Processing 00000000.tx.362: W., Lavu, S., Wood, J. 

Phrase: "W., Lavu,"

Phrase: "S."

Phrase: ","

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "J."
Processing 00000000.tx.363: G., Zipkin, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Zipkin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.364: E., Chung, P., Kisielewski, A., Zhang, L. 

Phrase: "E.,"

Phrase: "Chung,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kisielewski,"

Phrase: "A.,"

Phrase: "Zhang,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.365: L., Scherer, B., and Sinclair, D. 

Phrase: "L., Scherer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Sinclair,"

Phrase: "D."
Processing 00000000.tx.366: A. 

Phrase: "A."
Processing 00000000.tx.367: (2003) Nature 425, 191196[CrossRef][Medline] [OrderarticleviaInfotrieve] Araki, T., Sasaki, Y., and Milbrandt, J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nature 425,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "191196"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Araki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sasaki,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Milbrandt,"

Phrase: "J."
Processing 00000000.tx.368: (2004) Science 305, 10101013[Abstract/Free FullText] Parker, J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Science 305,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "10101013"

Phrase: "[Abstract/Free FullText"

Phrase: "] Parker,"

Phrase: "J."
Processing 00000000.tx.369: A., Arango, M., Abderrahmane, S., Lambert, E., Tourette, C., Catoire, H., and Neri, C. 

Phrase: "A.,"

Phrase: "Arango,"

Phrase: "M."

Phrase: ","

Phrase: "Abderrahmane,"

Phrase: "S."

Phrase: ","

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "E.,"

Phrase: "Tourette,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Catoire,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Neri,"

Phrase: "C."
Processing 00000000.tx.370: (2005) Nat. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.371: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.372: 37, 349350[CrossRef][Medline] [OrderarticleviaInfotrieve] Keller, J. 

Phrase: "37,"

Phrase: "349350"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Keller,"

Phrase: "J."
Processing 00000000.tx.373: N., Hanni, K. 

Phrase: "N., Hanni,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.374: B., and Markesbery, W. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.375: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.376: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.377: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.378: 75, 436439[CrossRef][Medline] [OrderarticleviaInfotrieve] Lopez Salon, M., Morelli, L., Castano, E. 

Phrase: "75,"

Phrase: "436439"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lopez Salon,"

Phrase: "M."

Phrase: ","

Phrase: "Morelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Castano,"

Phrase: "E."
Processing 00000000.tx.379: M., Soto, E. 

Phrase: "M."

Phrase: ","

Phrase: "Soto,"

Phrase: "E."
Processing 00000000.tx.380: F., and Pasquini, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Pasquini,"

Phrase: "J."
Processing 00000000.tx.381: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.382: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.383: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.384: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.385: 62, 302310[CrossRef][Medline] [OrderarticleviaInfotrieve] Gregori, L., Fuchs, C., Figueiredo-Pereira, M. 

Phrase: "62,"

Phrase: "302310"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gregori,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Fuchs,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Figueiredo-Pereira,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.386: E., Van Nostrand, W. 

Phrase: "E.,"

Phrase: "Van Nostrand,"

Phrase: "W."
Processing 00000000.tx.387: E., and Goldgaber, D. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Goldgaber,"

Phrase: "D."
Processing 00000000.tx.388: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.389: Biol. 

Phrase: "Biol."
Processing 00000000.tx.390: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.391: 270, 1970219708[Abstract/Free FullText] This Article Abstract Full Text (PDF) All Versions of this Article: 280/45/37377 most recent M508246200v1 Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Permissions Google Scholar Articles by Marambaud, P. 

Phrase: "270,"

Phrase: "1970219708"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "280/45/37377 most recent M508246200v1 Purchase Article View Shopping Cart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   801   C0441061:Shopping cart [Manufactured Object]
   788   C0179636:Cart [Manufactured Object]
   788   C1824528:CART [Gene or Genome]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Copyright Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1706852:Article [Intellectual Product]

Phrase: "by Marambaud,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.392: Articles by Davies, P. 

Phrase: "Articles by Davies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.393: PubMed PubMed Citation Articles by Marambaud, P. 

Phrase: "PubMed PubMed Citation Articles by Marambaud,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.394: Articles by Davies, P. 

Phrase: "Articles by Davies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.395: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Molecular and Cellular Proteomics Journal of Lipid Research Biochemistry and Molecular Biology Education Copyright  2005 by the American Society for Biochemistry and Molecular Biology.

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0039224:Table [Manufactured Object]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: "All ASBMB Journals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162443:journals [Intellectual Product,Manufactured Object]

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Cellular Proteomics Journal of Lipid Research Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Molecular Biology Education Copyright  2005 by the American Society"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   742   C0005532:Biology [Biomedical Occupation or Discipline]
   742   C0009993:Copyright [Intellectual Product]
   742   C0013621:Education [Educational Activity]
   742   C0013622:education [Classification]
   742   C0013658:Education, NOS [Finding]
   742   C0037455:society [Organization]
   742   C0039401:Education [Educational Activity]
   742   C0596070:American [Population Group]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

